Podcasts about bloomberg distinguished professor

This year's WNYC Health Convening with support from the Alfred P. Sloan Foundation continues with a look at the current state of cancer research in the United States. Sudip Parikh, Ph.D., chief executive officer of the American Association for the Advancement of Science (AAAS) and executive publisher of the Science family of journals, and Otis Brawley, professor of oncology at The Kimmel Cancer Center at Johns Hopkins, a Bloomberg Distinguished Professor at Johns Hopkin and co-editor of The Cancer History Project, and Julie Rovner, chief Washington correspondent at KFF Health News and host of the What the Health? podcast, discuss what the impacts of the Trump administration's funding cuts to the National Health Institute have meant to clinical trials, and what a future without government funding to find a cure might look like should the science continue to be underfunded.

About this episode: In today's episode: A discussion with Dr. Lisa Cooper, the director of the Johns Hopkins Center for Health Equity, about opposition to the terms "diversity," "equity," and "inclusion." Guests: Dr. Lisa Cooper is a public health physician, a Bloomberg Distinguished Professor at Johns Hopkins and a winner of a MacArthur genius grant for her work to understand and reduce health disparities. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Why Are Health Disparities Everyone's Problem?—Public Health On Call (February, 2022) Higher Bar For Health Care—Johns Hopkins Magazine Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

About this episode: For decades, regular mammograms to detect breast cancer have been recommended for women ages 50-75. In 2024, the age range dropped to include women 40-49 as well. But what do we really know about mammography as a tool to save lives? Are all scans created equal? What is the risk/benefit analysis to upping the number of screenings a woman is recommended to receive in her lifetime? In today's episode: a deep dive into the evidence around mammography, and a look at the new guidelines—including the controversy around them. Guest: Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control whose work focuses on developing cancer screening strategies and ensuring their effectiveness. He is a Bloomberg Distinguished Professor and faculty at the Johns Hopkins Bloomberg School of Public Health in epidemiology with a joint appointment in oncology at Johns Hopkins Medicine. He was the former Chief Medical Officer of the American Cancer Society. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Final Recommendation Statement: Breast Cancer Screening—U.S. Preventive Services Task Force The Rise of Colorectal Cancer Among Younger People—Public Health On Call (June 2024) Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

More than 150,000 Americans are diagnosed with colorectal cancer every year. And the average age of people who get them is dropping. The American Cancer Society says the share of colorectal cancer cases among those younger than 55 nearly doubled between 1995 and 2019, rising from 11 percent to 20 percent. Why is this happening? What can people do to reduce their risk of developing colorectal cancer? For answers, we turn to oncologist and epidemiologist Dr. Otis Brawley, a Bloomberg Distinguished Professor at Johns Hopkins University. Links:The Rise of Colorectal Cancers Among Younger PeopleBringing Informed Decision-Making to Cancer ScreeningDo you have a question or comment about a show or a story idea to pitch? Contact On the Record at: Senior Supervising Producer, Maureen Harvie she/her/hers mharvie@wypr.org 410-235-1903 Senior Producer, Melissa Gerr she/her/hers mgerr@wypr.org 410-235-1157 Producer Sam Bermas-Dawes he/him/his sbdawes@wypr.org 410-235-1472

Dr. Otis Brawley, Bloomberg Distinguished Professor of oncology and epidemiology at Johns Hopkins University, is passionate about cancer research, prevention and high-quality cancer care. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from 2007 to 2018 and has published over 200 scientific articles.   In this episode, Dr. Brawley speaks about the impact of socioeconomic factors on cancer rates. Smoking, obesity and poverty are leading causes of cancer in the United States. With cancer rates rising, Dr. Brawley emphasizes the importance of prevention and risk reduction, including healthy lifestyle choices such as regular exercise and a healthy diet. Dr. Brawley is passionate about reducing cancer care disparities and saving lives with accessible, high-quality care, including appropriate screening, diagnostics and treatments. Having the correct data and technology in place can help to identify high-risk individuals and plan interventions early to prevent diseases. Lastly, Dr. Brawley shares valuable insights on carcinogens and practical tips on how to prevent cancer.

About this episode: June 8 would mark the 80th birthday of Dr. Levi Watkins, Jr., a cardiothoracic surgeon at Johns Hopkins known for being part of the first team to implant an automatic defibrillator in a human patient. But Dr. Watkins was so much more: a civil rights and political activist, a champion of Black and other people who are underrepresented in medicine, and a snappy dresser with a great sense of humor. Today, two people who knew and worked with Dr. Watkins share their memories as we celebrate his legacy. Guests: Dr. Lisa Cooper is a public health physician, a Bloomberg Distinguished Professor, and a faculty member at the Johns Hopkins Bloomberg School of Public Health and School of Medicine. Steven Ragsdale is a former senior administrator at Johns Hopkins Hospital and a faculty member in Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Celebrating the Life and Legacy of Dr. Levi Watkins Jr.—YouTube Levi Watkins, 70, Dies; Pioneering Heart Surgeon Pushed Civil Rights—New York Times Levi Watkins Jr., pioneering Hopkins cardiac surgeon and civil rights activist, dies at 70—Johns Hopkins Hub Contact us: Have a question about something you heard? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Fungi have played an important role both in culinary and medicinal traditions for 1000s of years, but these magical living organisms are often overlooked - both for good and bad - when it comes to the future of our health and planet. What if a new heat-loving fungus takes over? What if a fungus holds the key to an anti-cancer or vaccination? We'll explore these questions and more on this week's podcast. Listen and learn: Microbial differences: bacteria, yeast, and fungi Risk of future fungal outbreaks Rewards of potential medicines and cures The known vs. unknown mystery of fungi Links Arturo Casadevall ABOUT OUR GUEST Arturo Casadevall is a physician-scientist and Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine. His research focuses on fungal and bacterial pathogenesis, antibody structure-function, and improving the scientific process. He's written a number of books, the newest is, What if fungi Win? Like the Show? Leave us a review Check out our YouTube channel

About the episode: Colorectal cancers are rising among people under age 50. There are a number of theories as to why and also promising data around early detection. In today's episode: A deep dive into the epidemiology of colorectal cancers including who is most at risk, a look at the screening tools currently available, and why blood tests may be even more valuable than costly and invasive colonoscopies. Guest: Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control whose work focuses on developing cancer screening strategies and ensuring their effectiveness. He is a Bloomberg Distinguished Professor and faculty at the Johns Hopkins Bloomberg School of Public Health in epidemiology with a joint appointment in oncology at Johns Hopkins Medicine. He was the former Chief Medical Officer of the American Cancer Society. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death—The New England Journal of Medicine A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening—The New England Journal of Medicine The Minnesota Colon Cancer Control Study Contact us: Have a question about something you heard? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.

Peter Agre received the 2003 Nobel Prize in Chemistry for his discovery of aquaporins. Peter is a Bloomberg Distinguished Professor in Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health, and he also directed the Johns Hopkins Malaria Research Institute until 2023. Today we discuss the history of malaria research, and Peter reflects on being a scientist. The interview is followed by Peter's keynote lecture for the University of Arizona One Health symposium, which he gave on February 12, 2024.

Dr. Otis Brawley, Bloomberg Distinguished Professor at Johns Hopkins University, joins the For Your Health News podcast to discuss his role in the fight for health care equity with the CEO Roundtable on Cancer and Johns Hopkins University. Dr. Brawley shares some findings from his work with HBCU's, highlights the importance of science-based detection and prevention methods, and assesses the state of cancer care in his home city of Baltimore and beyond. Join us for this conversation with an influential voice in the fight for health care equity. Learn more about the CEO Roundtable on Cancer and their efforts to eliminate cancer as a public health crisis: https://www.ceoroundtableoncancer.org/ Visit fyh.news for more health care information that empowers minoritized communities. Learn more about NMQF's Cancer Stage Shifting Initiative (CSSI): shiftcancer.org 00:00 Introductions 00:30 Defining the Cancer Problem 01:28 Working with HBCU's 02:04 Science-based Screening & Prevention 03:35 Cancer Care in Baltimore

The radius of the Earth is over 6,000 kilometers, but the deepest we've ever dug below the surface is only about 12 km. Yet we have a quite reliable idea of the structure of the Earth's interior -- inner core, outer core, mantle, crust -- not to mention pretty good pictures of what's going on inside some other planets. How do we know those things, and what new things are we learning in the exoplanet era? I talk with astrophysicist and planetary scientist Sabine Stanley about how we use gravitation, seismology, magnetic fields, and other tools to learn what's happening inside planets.Blog post with transcript: https://www.preposterousuniverse.com/podcast/2024/01/29/264-sabine-stanley-on-whats-inside-planets/?classic-editorSupport Mindscape on Patreon.Sabine Stanley received a Ph.D. in geophysics from Harvard University. She is currently a Bloomberg Distinguished Professor at Johns Hopkins University. She has been awarded the William Gilbert Award from the American Geophysical Union. Her recent book is What's Hidden Inside Planets?WebsiteJohns Hopkins web pagePublications from Google ScholarWikipediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“Our experience as humans make it challenging to grasp the conditions that occur inside the planet,” writes scientist Dr. Sabine Stanley. “There's just nothing like it in our everyday experience.” Stanley has dedicated her career to uncovering the mysterious inner workings of Earth and other planets in our solar system. Below a planet's surface can be a swirling world of wonder from magnetism, rotation, and volcanos. Stanley explores what makes planets tick in her new book What's Hidden Inside Planets. We talk to Stanley. Guests: Dr. Sabine Stanley, Bloomberg Distinguished Professor of Planetary Physics; fellow, Hopkins Extreme Materials Institute at Johns Hopkins University

In this episode of Talk Nerdy, Cara is joined by Dr. Sabine Stanley, a Bloomberg Distinguished Professor at Johns Hopkins University in the Department of Earth and Planetary Sciences and the Space Exploration Sector of the Applied Physics Lab. They talk about her newest book, "What's Hidden Inside Planets?" with a special emphasis on planetary magnetism.This show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/4530061/advertisement

In this weeks episode we are joined by Bloomberg Distinguished Professor at John Hopkins - Dr Sabine Stanley - to talk planetary science and her new book. We take a tour though the solar system and then get into the numerous surprises that have unfolded with our recent discoveries of exoplanets outside our solar system. We explore what we might find in a stellar backyard, but more importantly we talk about what we yet might learn about the earth and how planetary systems themselves work. Podcast interview with Dr Sabine Stanley Sabine's research involves understanding planetary interior processes and evolution. She focuses on planetary magnetic fields, dynamo theory, interior structure models and other geophysical methods to learn about the deep interiors of planets. Her work includes projects on many solar system bodies (Mercury, Moon, Earth, Mars, Jupiter, Saturn, Uranus, Neptune, asteroids and planetesimals) as well as extrasolar planets. She uses a combination of numerical simulations, theory and comparison to observations from various missions to explore her science questions. Brett King Bestselling Author, Founder, Radio Host www.thefuturists.com www.brettking.com See more breaking stories and podcasts here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

In this weeks episode we are joined by Bloomberg Distinguished Professor at John Hopkins - Dr Sabine Stanley - to talk planetary science and her new book. We take a tour though the solar system and then get into the numerous surprises that have unfolded with our recent discoveries of exoplanets outside our solar system. We explore what we might find in a stellar backyard, but more importantly we talk about what we yet might learn about the earth and how planetary systems themselves work.Brett KingBestselling Author, Founder, Radio Hostwww.thefuturists.comwww.brettking.com

In this weeks episode we are joined by Bloomberg Distinguished Professor at John Hopkins - Dr Sabine Stanley - to talk planetary science and her new book. We take a tour though the solar system and then get into the numerous surprises that have unfolded with our recent discoveries of exoplanets outside our solar system. We explore what we might find in a stellar backyard, but more importantly we talk about what we yet might learn about the earth and how planetary systems themselves work. 

As we boomers know, one of the best ways to ensure a long, healthy life is to keep our brains active by learning new and interesting information. And that's where today's guest today can really inspire us! Dr. Sabine Stanleyis a Bloomberg Distinguished Professor of Planetary Physics at Johns Hopkins University. Dr. Stanley focuses on observing magnetic fields and other geophysical elements as a way of studying the interiors of planets, moons, asteroids, and exoplanets. She's a participating scientist on the NASA Mars InSight mission and her work has been cited in numerous renowned publications including National Geographic Magazine, Bloomberg View, and the Washington Post. Dr. Stanley has written a newly released book entitled, What's Hidden Inside Planets?This comprehensive resource is filled with fascinating facts about the mysteries of the earth we inhabit as well as those to be found in our planetary neighbors. If you have a curious mind, you'll want to be sure to hear all about this expert's guide to unlocking some of the more baffling mysteries of our universe!

You may be familiar with some recent news about far-flung interstellar locations, like the Psyche Mission, Mars InSight Mission, and the Juno Mission to Jupiter.  Award-winning planetary scientist Dr. Sabine Stanley has been involved in some of these missions and is the author of the new book from Johns Hopkins Press, What's Hidden Inside Planets?  Thanks to Dr. Sabine and her team, our listeners can use promo code HPLAN for 30% off What's Hidden Inside Planets? when you order from Hopkins Press at press.jhu.edu. Link: https://www.press.jhu.edu/books/title/12879/whats-hidden-inside-planets?utm_source=radio_tour&utm_medium=podcast_radio_promo&utm_campaign=f23_stanley_hplan We were lucky enough to have Sabine on the podcast to share all about it for this episode of People of Science. She also shares her non-traditional STEM Origin story that starts in a small mining town in the middle of an impact crater! Available NOW on Spotify, Apple podcasts, Amazon Music, and Youtube! Please like, share, and subscribe!  More topics from this episode: How her interest in planetary interiors began. Some of the forces at work inside planets, and how they affect the surface and why to truly understand a planet on the outside, we must know what's happening on the inside. Some of the forces at work inside planets, and how they affect the surface and why to truly understand a planet on the outside, we must know what's happening on the inside. What the future holds for planetary exploration and if there are planets yet to be discovered.  What this planetary scientist thinks of Pluto, whether its a planet and the surprise of how YOUNG the King of the Kuiper Belt is after the New Horizons flyby Thoughts on Psyche, James Webb Telescope, OSIRIS-REx and more! Let us know what you think about this episode in the comments!  We'd love to know your thoughts and questions! Email us at todayinspacepodcast@gmail.com SOURCES: https://sabinestanley.com/aboutme/ https://sabinestanley.com/research/ Sabine Stanley, PhD, is a Bloomberg Distinguished Professor of Planetary Physics at Johns Hopkins University focusing on magnetic fields and other geophysical elements as a means of studying the interiors of planets, moons, asteroids, and exoplanets. She is a 2011 Alfred P. Sloan Research Fellow and received the William Gilbert Award of the American Geophysical Union in 2010. She's a participating scientist on the NASA Mars InSight mission investigating Mars's ancient magnetic field and leads the Magnetism & Planetary Interiors (MagPi) research group at Johns Hopkins. Her work has been featured in National Geographic Magazine, Bloomberg View, CBC Radio's Quirks and Quarks, and the Washington Post. She will be featured in the Summer 2024 BBC series “The Planets II,” and is the creator of The Great Courses lecture series “A Field Guide to the Planets.” -------------------------- Here's to building a fantastic future - and continued progress in Space (and humanity)! Spread Love, Spread Science  Alex G. Orphanos We'd like to thank our sponsors: AG3D Printing Follow us: @todayinspacepod on Instagram/Twitter @todayinspace on TikTok /TodayInSpacePodcast on Facebook Support the podcast: Get our 3D printed Starship Pen in our Etsy Shop Ag3dprinting.Etsy.com Buy a 3D printed gift from our shop - ag3dprinting.etsy.com Get a free quote on your next 3D printing project at ag3d-printing.com Donate at todayinspace.net #space #rocket #podcast #people #spacex #moon #science #3dprinting #nasa #tothemoon #spacetravel #spaceexploration #solarsystem #spacecraft #technology #carlsagan #aerospace #spacetechnology #engineer #alien #stem #listenable #iss #alienlife #astronomy #astrophysics #planetaryexploration #jameswebbspacetelescope #womeninspace #womeninstem #artandscience #globalfoundries #podcast #spacepodcast #sciencepodcast #spaceforce #geology #planetaryscience #planetaryscientist Timestamps 00:00 Planetary science and the challenges of exploring deep into the Earth's interior 01:49 Planetary science origin stories and mentorship. 04:52 Mentors, college experience, and planetary science research. 10:43 Planetary science and the study of magnetic fields. 14:08 Planetary formation and classification. 17:23 Exoplanet exploration and potential for life detection. 23:47 Space missions to metal asteroid Psyche and asteroid Bennu. 27:10 Space exploration and the analysis of asteroids. 33:54 Meteorites, impact craters, and geology. 37:32 Gravity, mass, and time in planetary science. 41:27 Moon formation, Pluto's status, and New Horizons mission. 47:39 Scientists' reluctance to admit uncertainty. 51:10 Space exploration and scientific growth. 

What do we know about what's happening deep inside Earth, and why does it matter? Dr. Sabine Stanley, a Bloomberg Distinguished Professor at Johns Hopkins University, joins the podcast to enlighten us. By focusing on planetary magnetic fields, dynamo theory, and other geophysical methods, Dr. Stanley is on a mission to uncover the deep interior of planets. From extrasolar worlds to planets within our own solar system, this research reveals many interesting facts about our universe – and we've only scratched the surface…  In this discussion, we explore: What the interior of our Earth is made up of.  Why it's so hard to study the interior of rocky planets. What “mantle convection” is, and the planetary functions it is responsible for.  The types of chemicals that are found beneath Earth's surface.  You can learn more about Dr. Stanley here, and purchase her latest book, What's Hidden Inside Planets?, here! Episode also available on Apple Podcast: http://apple.co/30PvU9C Use promo code HPLAN for 30% off What's Hidden Inside Planets? when you order from Hopkins Press at press.jhu.edu https://www.press.jhu.edu/books/title/12879/whats-hidden-inside-planets?utm_source=radio_tour&utm_medium=podcast_radio_promo&utm_campaign=f23_stanley_hplan

Health care leaders are spending more time and money trying to improve the way doctors and nurses talk with their patients, to build more trust. Are those efforts working? We eavesdrop on some difficult conversations between patients and providers, and meet researchers who are measuring the power of using just the right words. This episode first aired in 2019 and remains as relevant as ever.Guests:Andrea Anderson, MD, Medical Director, Unity Health CareSumeera Baig, MD, Physician, R-HealthCalvin Chou, MD, Professor, University of California, San FranciscoLisa Cooper, MD, MPH, Bloomberg Distinguished Professor, Equity in Health and Healthcare, Johns Hopkins University School of MedicineHannah Herman, DO, Resident, The Wright Center for Graduate Medical EducationLauren Howe, PhD, Postdoctoral Scholar, Stanford UniversityNatalie Levinson, patientJeff Milstein, MD, Regional Medical Director, Penn Primary CareKathy Trow, MSN, APN-C, Nurse Practitioner, Penn Medicine Jessika Welcome, mother of patient Natalie LevinsonLearn more and read a full transcript on our website.We're also excited to share that you can now find Tradeoffs on YouTube! Still not enough Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Climate change is possibly the major threat that planet earth is experiencing in this century with potential catastrophic consequences. As the planet warms, the change in weather patterns is affecting the microbial ecology in such a manner that humans are facing new health threats including emerging diseases and facing species of organisms that are more likely to survive these new climatic conditions and resist clinically useful antimicrobials. Topics discussed: The global threat of global warming. Climate change and change sin microbial ecology. The consequences of climate change and emergence of new infectious diseases and antimicrobial resistance patterns. Guests: Arturo Casadeval MD, Bloomberg Distinguished Professor, Alfred & Jill Sommer Professor and Chair Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health. Editor in Chief of mBio, Member of the National Academy of Sciences

What's behind the rise in tick-borne illness? And what can you do to protect yourself? Nicole Baumgarth is a Bloomberg Distinguished Professor of Molecular Microbiology and Immunology and the Johns Hopkins Bloomberg School of Public Health. She arrived last September to head the public health school's new Lyme and Tickborne Diseases Research and Education Institute. Learn more about the geography of tick-borne disease on the Johns Hopkins Lyme and Tickborne Disease Dashboard. Then, a conversation about the value of green space, no matter how small.  Katie Lautar is the executive director of Baltimore Green Space, a non-profit helping local communities manage and advocate for parks, gardens, and other pockets of nature in their neighborhoods. Sylvester Myers is part of Baltimore Green Space's Forest Stewardship Network. Find out more about how to get involved and learn more about the green spaces in your neighborhood on their website.  Do you have a question or comment about a show or a story idea to pitch? Contact On the Record at: Senior Supervising Producer, Maureen Harvie she/her/hers mharvie@wypr.org 410-235-1903 Senior Producer, Melissa Gerr she/her/hers mgerr@wypr.org 410-235-1157 Producer Sam Bermas-Dawes he/him/his sbdawes@wypr.org 410-235-1472

As shorts and tank-tops come out for summer, tiny blood-thirsty ticks see an all-you-can-eat buffet. Tick-borne illnesses have been climbing in the United States, a steady surge in several diseases carried by ticks like Lyme Disease and Babesiosis. Plus, most of us know about Patterson Park. But Baltimore is also home to hundreds of scattered, smaller pockets of green, too. And conservationist say they are critical to human and non-human inhabitants alike. Katie Lautar is Executive Director of Baltimore Green Space, a non-profit helping local communities manage and advocate for parks, gardens and other pockets of nature in their neighborhood Sylvester Myers also joins us. He's a community member who's part of Baltimore Green Space's Forest Stewardship Network. Find out more about how to get involved and learn more about the green spaces in your neighborhood on their website. But first, what's behind the rise in tickborne illness? And what can you do to protect yourself? Nicole Baumgarth is a Bloomberg Distinguished Professor of Molecular Microbiology and Immunology and the Johns Hopkins Bloomberg School of Public Health. She arrived last September to head the public health school's new Lyme and Tickborne Diseases Research and Education Institute. She is also a doctor of veterinary medicine. You can learn more about the geography of tickborne disease on the Johns Hopkins Lyme and Tickborne Disease Dashboard.See omnystudio.com/listener for privacy information.

I invited Dr. Steven Salzberg, a prominent bioinformatics scientist and the Bloomberg Distinguished Professor of Biomedical Engineering, Computer Science, and Biostatistics at Johns Hopkins University, on the podcast. In this episode, we talked about a lot of interesting topics from the role of bioinformatics in research, risks of gain-of-function research, and the Wuhan lab leak theory. ----------------------------------------- Thanks to the sponsors/partners: Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoat Newsly: https://newsly.mepromo code to receive a 1-month free premium subscription: EARLYMORNING Anchor https://anchor.fm Libysn https://libsyn.compromo code: DG Dubby Energy https://www.dubby.ggpromo code for 10% off: DIAMONDGOAT spikeview https://www.spikeview.comhttps://www.instagram.com/spikeview ---------------------------------------------------------------------------------- Listen on: Podcast website: https://anchor.fm/diamondgoat Spotify: https://open.spotify.com/show/0EuhA6WyuerHtVAqcFrFeO Google Podcast: https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy80NzE4MzM5MC9wb2RjYXN0L3Jzcw== RadioPublic: https://radiopublic.com/dg-earlymorning-show-WoML4r Breaker: https://www.breaker.audio/dg-early-morning-show Podcast YT channel clips: https://www.youtube.com/@dgearlymorningshow Reason: https://reason.fm/podcast/dg-earlymorning-show Apple Podcast: https://podcasts.apple.com/us/podcast/dg-early-morning-show/id1575451533 Amazon Music: https://music.amazon.com/podcasts/f050b86c-1dad-4bc3-b12f-6aa5fa62438c Tiktok: @dgearlymorningshow -------------------------------------- Check out my other stuff: Instagram: @itzdiamondgoat Twitter: @lildiamondgoat Main YT channel: youtube.com/diamondgoat Tiktok: @lildiamondgoat Soundcloud: @Lil Diamondgoat Spotify: @Lil Diamondgoat Merch store: https://diamondgoat.creator-spring.com --- Support this podcast: https://podcasters.spotify.com/pod/show/diamondgoat/support

Artificial Intelligence is getting good — like really good. In the past few months, new versions of AI chatbots have caught a lot of people off guard with how well Artificial Intelligence is doing human things like writing, creating art and even talking. Safe to say it's time we get to know what AI is and how to live with this new technology. Rama Chellappa — a Bloomberg Distinguished Professor in electrical and computer engineering and biomedical engineering and chief scientist at the Johns Hopkins Institute for Assured Autonomy — is a pioneer in the area of artificial intelligence. Professor Chellappa tells the story of AI, its ability, its potential and how we humans should interact with it. 

Artificial Intelligence is getting good — like really good. In the past few months, new versions of AI chatbots have caught a lot of people off guard with how well Artificial Intelligence is doing human things like writing, creating art and even talking. Safe to say it's time we get to know what AI is and how to live with this new technology. Rama Chellappa — a Bloomberg Distinguished Professor in electrical, computer, and biomedical engineering and chief scientist at the Johns Hopkins Institute for Assured Autonomy — is a pioneer in artificial intelligence. He is also the author of Can We Trust AI? Professor Chellappa tells the story of AI, its abilities, potential and how we should interact with it. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Artificial Intelligence is getting good — like really good. In the past few months, new versions of AI chatbots have caught a lot of people off guard with how well Artificial Intelligence is doing human things like writing, creating art and even talking. Safe to say it's time we get to know what AI is and how to live with this new technology. Rama Chellappa — a Bloomberg Distinguished Professor in electrical, computer, and biomedical engineering and chief scientist at the Johns Hopkins Institute for Assured Autonomy — is a pioneer in artificial intelligence. He is also the author of Can We Trust AI? Professor Chellappa tells the story of AI, its abilities, potential and how we should interact with it. Learn more about your ad choices. Visit megaphone.fm/adchoices

Otis Brawley is a globally-recognized expert in cancer prevention and control. He has worked to reduce overscreening of medical conditions, which has revolutionized patient treatment by increasing quality of life and reducing health disparities. Brawley's research focuses on developing cancer screening strategies and ensuring their effectiveness. He has championed efforts to decrease smoking and implement other lifestyle risk reduction programs, as well as to provide critical support to cancer patients and concentrate cancer control efforts in areas where they could be most effective. Brawley currently leads a broad interdisciplinary research effort on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, striving to close racial, economic, and social disparities in the prevention, detection, and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland. Brawley joined Johns Hopkins University as a Bloomberg Distinguished Professor in 2019 from the American Cancer Society and Emory University. And he is the author of the book How We Do Harm. Topics covered in this episode: Respect in Medicine Medical Devices Cancer Screenings Minorities in Treatment Sources of Healthcare Disparities Health Insurance Diet and Physical Activity The Future Of Medicine Creating Trust Drug Company Data Managing Conflict of Interest Breast Cancer Screening Referenced in the episode: The Lindsey Elmore Show Ep 174 | Overcoming Political Influence on Healthcare | John Abramson To learn more about Otis Brawley and his work, head over to https://research.jhu.edu/members/otis-brawley/ @otisbrawley __________________________________________________________ Amare's Happy Juice is a delicious combination of three popular products, including MentaBiotics, Edge and Energy+. Plus when you mix the three of them together, it creates one drink to help elevate your mood, crush your to-do list and enjoy every minute of the day. The three products that are in happy juice, boost mood and motivation, help to provide overall nourishment and help for your second brain a.k.a. your gut. It helps enhance mental performance and provides the fuel that you need for a highly productive day. Head to http://www.lindseyelmore.com/happyjuice to save $10 when you purchase the collection of Edge, MentaBiotics and Energy+ today! __________________________________________________________ Do you want to live a healthy lifestyle but you don't know where to find reliable health education, you don't have someone you can trust to lead you to which health and wellness options are out there. When you go to http://www.Wellnessmadesimple.us you can learn practical skills that you need to build a healthy lifestyle. You'll gain access to more than 85 videos, 11 hours of education and more education is always being added, and you'll join a community that has given more than 2400 positive reviews. All you have to do is get access, and right now we are offering half off of an annual subscription when you shop the code 2023Wellness and after that, watch the coursework, then implement daily changes positively transform your help you can feel better. Go to http://www.Wellnessmadesimple.us to get an annual subscription, and shop the code 2023Wellness for half off of your annual subscription. __________________________________________________________ __________________________________________________________ We hope you enjoyed this episode. Come check us out at www.lindseyelmore.com/podcast.

In this conversation, Robert Winn and Otis Brawley discuss the structural biases and racism that are present in law enforcement as well as in medicine after the killing of Tyre Nichols by police. Otis Brawley is Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University and co-editor of the Cancer History Project; and Robert Winn is director of the Virginia Commonwealth University Massey Cancer Center and guest editor of the Cancer History Project during Black History Month. In this episode, Brawley and Winn identify the racial and class power dynamics in American society, and why physicians and healthcare professionals have a responsibility to reflect on the problems in policing, and identify areas where these problems are also present in health care. Brawley and Winn have had their own potentially deadly encounters with police—Brawley was thrown to the ground and held at gunpoint for standing in the garage of his own home; Winn was thrown to the ground and held at gunpoint for walking toward his own car. A transcript of the episode is available here.

Dr. Otis Brawley joins the show to discuss reducing cancer overscreening and health disparities. ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. ABOUT DR. OTIS BRAWLEYOtis Brawley is a professor of oncology at the Johns Hopkins University School of Medicine and 39th Bloomberg Distinguished Professor at Johns Hopkins. Dr. Brawley leads a broad interdisciplinary research effort of cancer health disparities at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, working to close racial, economic and social disparities in the prevention, detection and treatment of cancer in the United States and worldwide.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedIn#cancerscreening #healthdisparities #oncology #health #caretalk #healthcarepodcast #healthcare

The baby boomer generation has encountered some major shifts that have greatly impacted our lives. Many of these monumental changes were totally unexpected back in our younger years, especially those around technology and Artificial Intelligence. Thankfully, there's no one better to speak with about this topic than our guest today, Rama Chellappa, Ph.D. Dr. Chellappa is a pioneering researcher and inventor in the fields of computer vision, artificial intelligence and machine learning. In addition to being a Bloomberg Distinguished Professor, Dr. Chellappa holds eight patents and is a Fellow of eight professional societies including the Institute of Electrical and Electronics Engineers, the Association for the Advancement of Artificial Intelligence and the Association for Computing Machinery and the National Academy of Inventors. And, for those of us who may fall a little short of his academic achievements, Dr. Chellappa has just come out with a book that both poses and explores a fascinating question that does impact all of our lives. His book is called: Can We Trust AI? And he joins us to share all about it. If you want to understand some of technologies more fascinating (and confounding) aspects, make certain you tune in for this one!

On episode 151, we welcome Rama Chellappa to discuss if we can trust Artificial Intelligence; the history of AI; how developments in AI have impacted social media, facial recognition, autonomous vehicles, and health; the problem of domain shifting when integrating health and lab data from various sources, which record data differently; AI racial bias in facial recognition technology; why AI recommender algorithms are not the only culprit in people subscribing to echo-chambers, which contribute to political polarization; our duty to utilize critical thinking to discern what's true and what isn't; the future of AI and the advancements that could be made in the fields of health and education; and why our relationship with AI should instill a sense of optimism about its future use. Use code HAI30 for 30% off Can We Trust AI? when you order from Hopkins Press. Order here: https://bit.ly/3tSZ6K6 Rama Chellappa, PhD (POTOMAC, MD), is a pioneering researcher and inventor in the fields of artificial intelligence, computer vision, and machine learning. A Bloomberg Distinguished Professor in electrical, computer, and biomedical engineering, he is also a member of the Johns Hopkins Center for Imaging Science, the Center for Language and Speech Processing, and the Malone Center for Engineering in Healthcare. A Fellow of the Association for the Advancement of Artificial Intelligence, the Institute of Electrical and Electronics Engineers, and the National Academy of Inventors, Dr. Chellappa holds eight patents. He is the recipient of IEEE's 2020 Jack S. Kilby Signal Processing Award and the 2012 K. S. Fu Prize fromthe International Association of Pattern Recognition. His work has been featured by the Associated Press, the BBC, and The New Yorker. His new book, available now, is called Can We Trust AI?  | Rama Chellappa | ► Website | https://aiem.jhu.edu ► Facebook | https://www.facebook.com/rama.chellappa.3 ► Can We Trust AI? Book | https://bit.ly/3tSZ6K6 Use code HAI30 for 30% off Can We Trust AI? when you order from Hopkins Press. Order here: https://bit.ly/3tSZ6K6 Where you can find us: | Seize The Moment Podcast | ► Facebook | https://www.facebook.com/SeizeTheMoment ► Twitter | https://twitter.com/seize_podcast ► Instagram | https://www.instagram.com/seizethemoment ► TikTok | https://www.tiktok.com/@seizethemomentpodcast ► Patreon | https://www.patreon.com/user?u=32208666  

Rama Chellappa, a Bloomberg Distinguished Professor in electrical and computer engineering and biomedical engineering and chief scientist at the Johns Hopkins Institute for Assured Autonomy, is a pioneer in the area of artificial intelligence. His work in computer vision, pattern recognition, and machine learning have had a profound impact on areas including biometrics, smart cars, […]

In this episode of the McKinsey Global Institute's Forward Thinking podcast, Janet Bush talks with Jessica Fanzo. Fanzo is the Bloomberg Distinguished Professor of Global Food Policy and Ethics at the Berman Institute of Bioethics, the BloombergSchool of Public Health, and the Nitze School of Advanced International Studies at Johns Hopkins University in the United States. From 2017 to 2019, Fanzo served as the co-chair of the Global Nutrition Report and the UN High Level Panel of Expertson Food Security and Nutrition. She was the first laureate of the Carasso Foundation's Premio Daniel Carasso prize in 2012 for her research on sustainablefood and diets for long-term human health.See www.mckinsey.com/privacy-policy for privacy information

Dr. Cardinale Smith, of the Mt. Sinai Health System, and Dr. Stephanie Wheeler, of the UNC Lineberger Comprehensive Cancer Center, discuss key research featured at the 2022 ASCO Quality Care Symposium, including practical solutions to advance equity, new trends in cancer care delivery, and novel approaches in palliative and supportive care.   TRANSCRIPT Dr. Cardinale Smith: Welcome to the ASCO Daily News podcast. I'm Dr. Cardinale Smith, a professor in the division of Hematology and Medical Oncology and Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai in New York, and the chair-elect of the 2022 ASCO Quality Care Symposium. I'm your guest host today and delighted to welcome the chair of the Symposium, Dr. Stephanie Wheeler. Dr. Wheeler is a professor in the Department of Health Policy and Management and associate director of Community Outreach and Engagement at the University of North Carolina Leinberger Comprehensive Cancer Center. We'll be discussing practical solutions and key research to advance equity and quality in cancer care, new trends in cancer care in the home and local community, novel approaches in palliative and supportive care, and other key takeaways from the meeting. Our full disclosures are available in the transcript of this episode, and disclosures relating to all episodes of the ASCO Daily News podcast are available on our transcripts at: asco.org/podcasts. Dr. Wheeler, it's great to be speaking with you today. Dr. Stephanie Wheeler: Thank you, Dr. Smith. I'm excited to be here. Dr. Cardinale Smith: Well, I'm super excited that I just got to see you, and it was fantastic that we had a hybrid event that really allowed our participants to meet in person and allowed folks who couldn't be in person to participate virtually. Cancer health equity was a major theme this year with sessions that explored how to incorporate equity into our work. Can you highlight a few takeaways for us? Dr. Stephanie Wheeler: Absolutely. And yes, it was such a delight to see you in person. And I'll just note that at this 10th anniversary of the Quality Care Symposium, we had record attendance - over 700 participants. So, I was really excited to have that level of engagement in this meeting. So, you know that as a planning committee, we really prioritized centering equity in our content this year, and I think it was reflected in every session at the meeting. Our very first educational session featured Drs. Chanita Hughes Halbert, Meera Vimala Ragavan, Victoria Blinder, and Sam Cykert, as well as community advocate, Terrence Muhammad, from the Greensboro Health Disparities Collaborative. Together, they provided important foundational and conceptual context to really set the stage for the rest of the meeting. Most importantly, they discussed specific evidence-based interventions designed to improve racial, socioeconomic, and rural health equity. These included the Accure Realtime Health Alerts Intervention with Navigation and Bias Training and Financial Hardship screening. Later in the meeting, we heard from Dr. Joannie Ivory presenting Abstract 68, who shared that we really need to take our trials where minoritized and historically disadvantaged populations live. In that study, geographic areas with greater numbers of black residents did a better job recruiting black participants to clinical trials, and the trial itself built in structural factors designed to ensure that at least 30% black participants were accrued. I also want to shine a light on the wonderful abstracts that were presented by Drs. Qasim Hussaini and Qinjin Fan, Abstract 69 and 3, which focused on association between historical housing discrimination and modern-day mortgage discrimination in colon and lung cancer treatments and outcomes respectively. I think this work just further underscores that racism is structural and societal and that we need to be paying attention to not only how we deliver oncology care, but policy in the banking world, the housing world, education, transportation infrastructure, and so much more, if we're serious about undoing disparities in cancer. Dr. Cardinale Smith: Yeah, and I'm probably biased since I had a role in planning this meeting. I definitely appreciate the focus on not just calling out these issues, but really thinking about how we start implementing interventions to really overcome them. Thank you for that really wonderful summary. The symposium also featured many trends in quality care, such as patient-reported outcomes measurement to monitor quality and patients' experiences. What are the sessions and abstracts that you think will give our listeners new ideas about how to integrate patient-reported outcomes into real-world settings? Dr. Stephanie Wheeler: Well, as you know, this continues to be an ongoing theme of the ASCO Quality Symposium. And I was really particularly encouraged this year that the focus was on implementation of PRO monitoring in real-world settings. So, just to highlight a few of the sessions that stood out to me were, dual abstracts 243 and 242 that were presented by Drs. Sandra Wong and Jessica Bian, showing symptom-reporting implementation in the medical oncology space, as well as the surgical oncology space, participating in the eSyM study at multiple cancer centers. In addition, we had an educational session that followed in which Drs. William Dale, Manali Patel and Sarah Hawley, presented work describing their efforts to implement geriatric assessment, multimodal symptom-control monitoring interventions in racially diverse populations, and a prostate cancer symptom-focused self-management intervention respectively. Then towards the end of the meeting, we also heard from Mike Hassett, presenting Abstract 241, who talked about differences in web versus mobile devices for ePRO reporting, and how those can really elicit different types of symptoms that are reported by different types of patients. We know that the digital divide is real in America, and so as we think about how to get patients to report their symptoms in meaningful, actionable ways in real-time, we have to be mindful of the modalities in which we're eliciting those symptoms. So, it's clear to me that the discussion has really moved beyond why we need to monitor patient-reported outcomes. I think Ethan Basch's work and others has really demonstrated that clearly to how best we can optimize it for patients' benefits while working within the constraints of existing EHRs and workflows, and of course, the constraints of our Wi-Fi connectivity in rural communities. Let me ask you a question. How about that? So, the palliative care abstract track was a new feature this year, and I was really excited about it. And I'd really love to know from your perspective as a specialist in Geriatrics and Palliative Medicine, how do new approaches that are going to be important in oncology best meet the needs of our patients? And how did this year's session content advance that field directly? Dr. Cardinale Smith: In addition to the implementation of patient-reported outcomes, which you spoke about, which I think is really incredibly critical, especially because we know that the data suggests that that's also associated with not only improvement of quality of life, but also survival. I was really excited to help moderate a session along with Dr. Shanthi Sivendran on the panel focused around advanced care planning, and really thinking about, "Is it time for a change?" And so, on that panel with us, were experts leading advanced care planning, Drs. Alcorn, Hickman, Montgomery, Paladino, and Rhodes. And really the topic of the conversation centered on changing the frame of thinking away from focusing just on documentation, but more about the conversation itself, and the focus on goal-concordant care, and how do we align goals and values with the cares received, and how do we talk about that? We also talked about how we align that with measurement. So, as we move towards value-based care in Oncology, how do we have better outcome measurements to capture impact? Like recently approved measures in the palliative care space of being seen and heard that was discussed. And shifting gears a little bit, we heard in an oral abstract presentation number 300 by Dr. Riaz, talking about outcomes of hospitalized patients with solid cancers receiving immunotherapy. We know that that is a group who are often receiving treatment closer to the end of their life in the hospital setting, and we don't have lots of data about how successful those treatments are. And what that data demonstrated among 159 patients over four academic medical centers, is that about approximately 30% of them who received inpatient immunotherapy actually died in the hospital. And so, I think that has really important implications as we think about the quality of life for these patients, as we also think about those quality metrics that we have to be adherent to. Continuing to think about how that impacts financial stressors for patients. You know, financial toxicity is a recurring theme at many of our ASCO meetings, and at this Quality meeting, we had a session that featured a multi-layered approach to financial toxicity solutions. Can you tell us about some of the key features of this approach? Dr. Stephanie Wheeler: Of course. Yeah. This was a wonderful session. I just have to note that the session on advanced care planning, one of the things that I really loved about that, before I talk about financial toxicity, was that the roundtable focus of that session, that particular modality, I think, just lent itself so well to the type of discussion that we were having, and it just felt very interactive. We had lots of great input from the audience, and I've continued to hear, since the meeting, that people really appreciated that. And I have to attribute your leadership there to thinking carefully about how to do that session. So, we should think about that more in the future as well. Turning to financial toxicity, this, like equity, I think, was a recurring theme of this meeting. And in particular, I think the poster sessions also covered a lot of content in the financial hardship space. So, you mentioned the educational session focused on multi-layered approaches to solutions here. And this session featured new work from folks like Dr. Maria Pisu, Samilia Obeng-Gyasi, and Emeline Aviki, and they were all talking about interventions in their cancer centers that were focused on timely identification of financial hardship, and different ways in which it can be screened for and that it can be actionably responded to. And then, Dr. Aviki described approaches that their center has used to really develop a multidisciplinary financial working group to address concerns. And I thought that was really creative and showed that all of the right stakeholders were at the table at Memorial Sloan Kettering. And then that session finished with remarks by Joanna Morales about the legal parameters of financial hardship, which I think are increasingly being understood as a really important determinant of poor outcomes. And we all know the legal system is incredibly difficult to navigate for people who don't have a legal background, and I love that she described some of the actionable ways in which people can do things like: better understand their employment protections, better advocate for themselves to be sure that their workplace accommodations are being responded to, and also thinking about their ability to advocate more for themselves when it comes to things like social security, disability insurance applications, and the legal parameters there. She also talked about policy options, and so I think this is a must-listen-to session for anybody who's interested in thinking about screening for and developing institution-wide efforts to address financial hardship through identification, and through legal approaches and levers that can mitigate and hopefully prevent it. By next year, I think it's important that we know that there are at least five NCI-funded clinical trials underway that are testing additional navigation and insurance literacy interventions in multi-sites across the country. And so, I think it'll be really important to see what happens with those studies as they move forward. And there is an NCI-supported financial hardship session and workshop that is happening later this week that Dr. Janet De Moor invited all ASCO Quality attendees to come to. So, more on this, I think in the future, but I don't see this as a topic that will be left off the agenda for the ASCO Quality Symposium for many years to come. Dr. Cardinale Smith: Yeah, and hopefully we'll be able to have some of that data presented at the next meeting next year. And just following up on that theme of financial burdens for our patients, I really would like to encourage anyone who didn't get a chance to hear this year's keynote lecture from Dr. Ezekiel Emanuel of The University of Pennsylvania, to really take some time and go take a listen to it. Dr. Emanuel focused on payment structure and models and had several key takeaways that I thought were really important. His main conclusions were that we need to think through new policies related to drug pricing and accelerated approval, as these have really important implications for the cost of cancer care. He also talked about how oncologists and those of us in the cancer care space and cancer care delivery space, have an increasing role to sort of nudge the NIH to think about their role in the research and development process for drugs, and to boost clinical trial enrollment. Specifically thinking about the enrollment of minoritized populations. And then lastly, and probably most provocative, which is one of the reasons why we really wanted him to come and to speak at this meeting, is that we know financial toxicity is significant and needs to be addressed. And he proposed that once a person is diagnosed with cancer, insurance companies, Medicare, should eliminate any deductibles, co-payments, or co-insurance, and other types of cost-sharing for our cancer patients, which I think is an interesting viewpoint. Dr. Stephanie Wheeler: Yeah, I couldn't agree more. And as a health policy scholar, I was sort of jumping in my seat with excitement over some of the bold and innovative solutions that he put forward. I think another compelling speaker, and I know you'll agree with me, is Dr. Otis Brawley. He's the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University, and he was honored with the Joseph Simone Quality Care Award, which of course, is focused on, really, lifetime achievements in the areas of quality care delivery in cancer. He's been such a champion of cancer care equity, and really has devoted his whole career to advancing cancer prevention, screening, and treatment strategies, to end the racial, socioeconomic, and rural disparities that we see in prevention, detection, and treatment of cancer. One of the things that he really emphasized that I appreciated is that we have to be more thoughtful about the ways in which we think about cancer health disparities, recognizing that more treatment is not always good treatment, and the more money that we spend on futile treatments and unnecessary treatments, and unnecessary care, that actually wastes resources that we could have otherwise distributed more fairly to our marginalized and minoritized populations. And so, he made a very direct argument between overspending, overdiagnosis, and overtreatment in cancer, and how that actually contributes to disparities in care, and disparities in outcomes. And I think that that really motivates us to not only look at the national movements in health policy reforms as important to do from an efficiency perspective and from a cost-control perspective because we know that healthcare costs in America are wildly out of sync with the rest of the world and unsustainable, but also because they're a key contributor to differences and outcomes that we see, and that we have a moral imperative to address. So, I was just really inspired by his talk. He covered so much territory in a small amount of time, and I think his talk in particular, combined with Dr. Emanuel's talk, really set the stage for us to think about the integration of policy, and equity, and care delivery together as we move forward in this field. Dr. Cardinale Smith: Yeah, I am definitely a fan, and I think to highlight both of them, there are tangible things that we can all walk away in our everyday lives and start putting into practice, which I think is key for us to move the needle on any of these things. Dr. Stephanie Wheeler: Yes. And I might say just in response to that, that towards the end of the session, we had that great oral abstract session that Melissa Simon and Blase Polite were the discussants for, and they really continued this theme of not just really unpacking these deeply-rooted social and historical root determinants of differences in outcomes, differences in quality, and problematic equity issues in cancer care delivery. But I think that they also gave us a number of things, as you said, that each of us can do in a more meaningful way on a daily basis. You know, being more aware, promoting others, sponsoring others from different backgrounds, really standing aside and allowing others to shine, and that has been a theme of this meeting. It's something that we wrote about last year, that this meeting is a place where junior scholars and trainees can come and connect and can really find not only a place here but can find a stage here. And so, I think some of the comments that they encouraged us to think about were specifically related to professional development and lifting up others, and paying it forward, and it resonated with me, in addition to the many other things they suggested around just how our healthcare systems are designed, and how we need to break down barriers. Dr. Cardinale Smith: Well said. I could not have said it any better. Thank you, Dr. Wheeler, for coming on the podcast to give us these highlights from the 2022 ASCO Quality Care Symposium. Our listeners can find the links to the abstracts we've discussed on the transcript of this episode. Dr. Stephanie Wheeler: Thank you, Dr. Smith. It's my pleasure to be here with you today and to have co-hosted this planning committee and this meeting with you, and I am so thrilled for your leadership next year as you take the gavel, take the stage, and lead us forward. Dr. Cardinale Smith: I can't wait to get started. And to you, our listeners, thank you for your time today. If you value the insights that you hear on the ASCO Daily News podcast, please take a moment to rate, review, and subscribe wherever you get your podcast. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy, should not be construed as an ASCO endorsement. Follow today's speakers: Dr. Cardinale Smith @cardismith  Dr. Stephanie Wheeler @StephWheelerUNC Want more related content? Listen to our podcasts on interventions to address financial toxicity. A Novel Approach to Address Financial Toxicity Dr. Derek Raghavan Has a Remedy to Mitigate Financial Toxicity in Cancer Treatment Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Stephanie Wheeler: Research Funding (institution): Pfizer Foundation Travel, Accommodations, Expenses: Pfizer Dr. Cardinale Smith: None to disclose

I ask the philosopher Hanna Pickard five questions about herself. Hanna Pickard is Bloomberg Distinguished Professor of Philosophy and Bioethics at Johns Hopkins University. She is the author of “Responsibility without Blame” (2011), “Addiction and the Self” (2021) and other essays in moral psychology.

I ask the philosopher Ian Phillips five questions about himself. Ian Phillips is Bloomberg Distinguished Professor of Philosophy and Brain Sciences at Johns Hopkins University. He is the author of “Perceiving Temporal Properties” (2010), “The Temporal Structure of Experience” (2014), and other essays.

Rev. Al and I are so pleased to bring the amazing story of Bloomberg Distinguished Professor Dr. Lawrence Jackson to our ever growing audience.  This guy is cool, I mean real cool, he's an expert on the History of Baltimore and he has rewriten the experience of African Americans and their contributions to the history and culture of our beloved city.  This is a lesson Podcast, learn about the music scene in Baltimore, especially the early Jazz scene here in Baltimore, learn about how Baltimore was also one the the places where Civil Rights legilation was written by Baltimore's own the Hon. Senator Clarence Mitchell. He has launched the Billy Holiday Center for Liberation Arts, he's way into Jazz and makes it real clear that Jazz came from Baltimore, as much as it came from NOLA.  He's written biographies on Ralph Ellison and Chester B. Hines, he's a Baltimore native, loves the place and is bent on seeing a brighter future for all Baltimorean's.  There is a deep rich History in the African American community here in Baltimore, and there's no better man to speak to it than Dr. Larry Jackson.  Come along for this one and learn about this incredible mans journey and have a look into the mind of a scholar who loves his city. Here we go! Thanks Dr. Jackson for joining us and shining your light.    

Chat with Nobel Prize winner Adam Riess about his team's newest measurements of the 'most important number in cosmology' the Hubble Constant. Using the Hubble Space Telescope for what it was meant to do, Adam's team continues to make ultra-precise measurements. We'll also explore the Hubble Tension, the future of Hubble now that the James Webb Space Telescope has deployed, and other cosmic conundrums. Adam is a brilliant teacher and a wonderful raconteur. Don't miss your chance to chat with a brilliant scientist about the most important topic in cosmology today! From the team: https://hubblesite.org/contents/news-releases/2022/news-2022-005 From CNN: Measuring the expansion rate of the universe was one of the Hubble Space Telescope's main goals when it was launched in 1990. Over the past 30 years, the space observatory has helped scientists discover and refine that accelerating rate – as well as uncover a mysterious wrinkle that only brand-new physics may solve. Hubble has observed more than 40 galaxies that include pulsating stars as well as exploding stars called supernovae to measure even greater cosmic distances. Both of these phenomena help astronomers to mark astronomical distances like mile markers, which have pointed to the expansion rate. In the quest to understand how quickly our universe expands, astronomers already made one unexpected discovery in 1998: “dark energy.” This phenomenon acts as a mysterious repulsive force that accelerates the expansion rate. And there is another twist: an unexplained difference between the expansion rate of the local universe versus that of the distant universe right after the big bang. Scientists don't understand the discrepancy but acknowledge that it's weird and could require new physics. “You are getting the most precise measure of the expansion rate for the universe from the gold standard of telescopes and cosmic mile markers,” said Nobel Laureate Adam Riess at the Space Telescope Science Institute and a distinguished professor at the Johns Hopkins University in Baltimore, in a statement. “This is what the Hubble Space Telescope was built to do, using the best techniques we know to do it. This is likely Hubble's magnum opus, because it would take another 30 years of Hubble's life to even double this sample size.” Adam Guy Riess (born December 16, 1969) is an American astrophysicist and Bloomberg Distinguished Professor at Johns Hopkins University and the Space Telescope Science Institute. He is known for his research in using supernovae as cosmological probes. Riess shared both the 2006 Shaw Prize in Astronomy and the 2011 Nobel Prize in Physics with Saul Perlmutter and Brian P. Schmidt for providing evidence that the expansion of the universe is accelerating. https://www.stsci.edu/~ariess/ Please Visit our Sponsors: LinkedIn: LinkedIn.com/impossible to post a job for FREE Athletic Greens, makers of AG1 which I take every day. Get an exclusive offer when you visit https://athleticgreens.com/impossible AG1 is made from the highest quality ingredients, in accordance with the strictest standards and obsessively improved based on the latest science. Connect with Brian: https://twitter.com/DrBrianKeating  https://facebook.com/losingthenobelprize  https://instagram.com/DrBrianKeating  Please join my mailing list; just click here http://briankeating.com/mailing_list.php  Produced by Stuart Volkow (P.G.A) and Brian Keating Edited by Stuart Volkow Music:  Yeti Tears Miguel Tully - www.facebook.com/yetitears/ Theo Ryan - http://the-omusic.com/

Chat with Nobel Prize winner Adam Riess about his team's newest measurements of the 'most important number in cosmology' the Hubble Constant. Using the Hubble Space Telescope for what it was meant to do, Adam's team continues to make ultra-precise measurements. We'll also explore the Hubble Tension, the future of Hubble now that the James Webb Space Telescope has deployed, and other cosmic conundrums. Adam is a brilliant teacher and a wonderful raconteur. Don't miss your chance to chat with a brilliant scientist about the most important topic in cosmology today! From the team: https://hubblesite.org/contents/news-releases/2022/news-2022-005 From CNN: Measuring the expansion rate of the universe was one of the Hubble Space Telescope's main goals when it was launched in 1990. Over the past 30 years, the space observatory has helped scientists discover and refine that accelerating rate – as well as uncover a mysterious wrinkle that only brand-new physics may solve. Hubble has observed more than 40 galaxies that include pulsating stars as well as exploding stars called supernovae to measure even greater cosmic distances. Both of these phenomena help astronomers to mark astronomical distances like mile markers, which have pointed to the expansion rate. In the quest to understand how quickly our universe expands, astronomers already made one unexpected discovery in 1998: “dark energy.” This phenomenon acts as a mysterious repulsive force that accelerates the expansion rate. And there is another twist: an unexplained difference between the expansion rate of the local universe versus that of the distant universe right after the big bang. Scientists don't understand the discrepancy but acknowledge that it's weird and could require new physics. “You are getting the most precise measure of the expansion rate for the universe from the gold standard of telescopes and cosmic mile markers,” said Nobel Laureate Adam Riess at the Space Telescope Science Institute and a distinguished professor at the Johns Hopkins University in Baltimore, in a statement. “This is what the Hubble Space Telescope was built to do, using the best techniques we know to do it. This is likely Hubble's magnum opus, because it would take another 30 years of Hubble's life to even double this sample size.” Adam Guy Riess (born December 16, 1969) is an American astrophysicist and Bloomberg Distinguished Professor at Johns Hopkins University and the Space Telescope Science Institute. He is known for his research in using supernovae as cosmological probes. Riess shared both the 2006 Shaw Prize in Astronomy and the 2011 Nobel Prize in Physics with Saul Perlmutter and Brian P. Schmidt for providing evidence that the expansion of the universe is accelerating. Connect with Brian: https://twitter.com/DrBrianKeating  https://facebook.com/losingthenobelprize  https://instagram.com/DrBrianKeating  Please join my mailing list; just click here http://briankeating.com/mailing_list.php  Produced by Stuart Volkow (P.G.A) and Brian Keating Edited by Stuart Volkow Music:  Yeti Tears Miguel Tully - www.facebook.com/yetitears/ Theo Ryan - http://the-omusic.com/

Dr. Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases, as well as a recent inductee to the National Academy of Sciences. Today, he joins us to discuss his research into convalescent plasma in the fight against COVID-19.

Where have efforts to reconstruct patient safety failed and what opportunities exist to remake the landscape of patient safety? How can advances in data technologies and systems thinking help us revolutionize over the next decade? Join host Karen Wolk Feinstein and esteemed guests Dr. Kathleen Sutcliffe, Bloomberg Distinguished Professor at Johns Hopkins University, and Dr. Vivian Lee, president of health platforms at Verily Life Sciences, for a glimpse into the potential for a collaborative, tech-enabled transformation of healthcare safety. View show notes and a transcript of this episode here.

Where have efforts to reconstruct patient safety failed and what opportunities exist to remake the landscape of patient safety? How can advances in data technologies and systems thinking help us revolutionize over the next decade? Join host Karen Wolk Feinstein and esteemed guests Dr. Kathleen Sutcliffe, Bloomberg Distinguished Professor at Johns Hopkins University, and Dr. Vivian Lee, president of health platforms at Verily Life Sciences, for a glimpse into the potential for a collaborative, tech-enabled transformation of healthcare safety. View show notes and a transcript of this episode here.

For decades, political discourse in Baltimore has included condemnation of the fact that there are “two Baltimores,” one in which opportunity abounds and the other in which systemic racism and inequity create insurmountable barriers. Tom's guest today has lived in both Baltimores, and he has written a fascinating memoir that paints a vivid portrait of these two disparate worlds, and of himself. It is a portrait that is richly detailed, expertly researched, and beautifully enlarged by insight, candor and a fair dollop of iconoclasm. Dr. Lawrence Jackson is a Bloomberg Distinguished Professor of English and History at Johns Hopkins University, and the founding director of the Billie Holiday Center for the Liberation Arts. He's the author of several books on the history of African American writers and critics, the Black crime novelist Chester B. Himes, and the author Ralph Ellison. He also wrote a book about his family's history in Virginia after the Civil War. His latest book is, in part, another work of family history. It's called Shelter: A Black Tale of Homeland, Baltimore. Dr. Lawrence Jackson joins us on Zoom from Baltimore. Dr. Jackson will discuss the book (again) with Tom Hall Wednesday night (May 11) with an audience at The Church of the Redeemer in Baltimore, a place that figures prominently in the book. The event is co-sponsored by The Ivy Bookshop, and starts at 7:00. For more information, click here. See omnystudio.com/listener for privacy information.

In conversation with Solomon Jones. Lawrence Jackson's award-winning books include The Indignant Generation: A Narrative History of African American Writers and Critics, biographies of Chester Himes and Ralph Ellison, and a memoir about his family history, titled My Father's Name: A Black Virginia Family after the Civil War. A Bloomberg Distinguished Professor of English and history at Johns Hopkins University, he is also the founder of the Billie Holiday Center for Liberation Arts and a recipient of a 2019 Guggenheim Fellowship. Shelter is an essay collection that begins with Jackson's initial struggle to make Baltimore his home and how his later adoption of the Charm City became a means to reexamine his personal history. An award-winning Philadelphia Daily News columnist and morning host for 900 am WURD radio in Philadelphia, Solomon Jones is the author of the Essence bestselling novel The Bridge, as well as the critically acclaimed books Pipe Dream, Ride or Die, Payback, and Ten Lives, Ten Demands: Life and Death Stories, and a Black Activist's Blueprint for Racial Justice. He is also a blogger and frequent on-air commentator for NPR-affiliate WHYY and is the founder of Words on the Street Literacy Program and the Rally for Justice Coalition. (recorded 5/4/2022)

The panel, which met Feb. 23, 2022, discussed the impact of systemic racism, the history of the health equity movement, and the crucial role of mentorship. Panelists: Robert A. Winn, MD Guest editor, Cancer History Project; Director and Lipman Chair in Oncology, VCU Massey Cancer Center; Senior associate dean for cancer innovation and professor of pulmonary disease and critical care medicine, VCU School of Medicine Otis W. Brawley, MD Co-editor, Cancer History Project; Bloomberg Distinguished Professor of Oncology and Epidemiology, Johns Hopkins University Edith P. Mitchell, MD Member, President's Cancer Panel; Clinical professor of medicine and medical oncology, Department of Medical Oncology; Director, Center to Eliminate Cancer Disparities; Associate director, diversity affairs; Sidney Kimmel Cancer Center at Jefferson, Thomas Jefferson University John H. Stewart, MD, MBA Professor of surgery, Section of Surgical Oncology; Founding director, LSU Health/LCMC Health Cancer Center A full transcript of this discussion, as well as a video, are available here: https://cancerhistoryproject.com/article/black-history-month-panel-we-need-to-talk-about-justice/

Dr. Ashani Weeraratna, Ph.D., (https://publichealth.jhu.edu/faculty/3918/ashani-t-weeraratna) is Bloomberg Distinguished Professor, Chair, Biochemistry & Molecular Biology, and Professor, Johns Hopkins Bloomberg School of Public Health. Dr. Weeraratna is also a recently appointed member (by President Joe Biden), of the National Cancer Advisory Board (https://deainfo.nci.nih.gov/advisory/ncab/ncab.htm), which advises and assists the director of the National Cancer Institute on the activities of the national cancer program. Dr. Weeraratna is a groundbreaking researcher exploring crucial questions about the role aging plays in cancer and her findings on age-related differences in responses to both targeted therapy and immuno-therapy for cancer are leading to a change in clinical practice. Dr. Weeraratna studies the molecular mechanisms involved in metastasis and how tumor micro-environments affect melanoma progression and therapy resistance. She is interested in how the aging micro-environment guides changes leading to increased metastasis and therapy resistance, as well as cell-autonomous aspects of therapy resistance. Dr. Weeraratna's research also encompasses biophysical changes that affect the ability of both tumor and immune cells to migrate. She has demonstrated that normal age-related changes in the micro-environment can contribute to multiple aspects of melanoma formation and development as well as therapy resistance. Dr. Weeraratna's work in melanoma prevention includes a public health approach. She recently helped lead a campaign to introduce sunblock dispensers throughout Philadelphia and talk to children about the dangers of tanning. Dr. Weeraratna is also the author of Is Cancer Inevitable? which clearly describes cancer's mechanisms and how teams like hers are finding ways to reduce its deadly impacts. The book is part of the Johns Hopkins Wavelengths series. Dr. Weeraratna joined Johns Hopkins University as a Bloomberg Distinguished Professor in 2019 from the Wistar Institute where she established her lab back in 2011, and prior to that was at the National Institute on Aging, since 2003. Dr. Weeraratna earned a doctorate in Molecular and Cellular Oncology from George Washington University Medical Center and completed post-graduate training and was a postdoctoral fellow in experimental therapeutics and pharmacology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, then known as the Johns Hopkins Oncology Center. 

In this episode, Dr. Eliana Perrin discusses the importance of clinicians and caregivers in childhood obesity prevention. She talks about how parents can help their children establish healthy habits from an early age and how clinicians can better intervene to prevent childhood obesity during and beyond the COVID-19 pandemic. Tune in to learn how healthcare providers can better equip parents and caregivers to prevent childhood obesity. Dr. Eliana Perrin is a general pediatrician, researcher, and expert in childhood obesity prevention and treatment. She focuses on communities that have been systematically disadvantaged. She studies how primary care teams can partner with families to help them engage in healthy behaviors throughout their child's life. She is a Bloomberg Distinguished Professor in the dept of pediatrics and schools of medicine, nursing, and public health. “And at the end of the day, it's important that our interactions with patients give them important information, allow them to be empowered to change whatever behaviors they're motivated to change for the reasons that are consistent with their values.” Question of the Day: What habit do you do every day to stay healthy? On this Episode you will Learn: Child Obesity in the United States Navigating “Toxic Food Environments” COVID-19's Impact on Childhood Obesity Improvements in Patient-Provider Interactions How Caregivers can Promote Healthy lifestyles Connect with Dr.Perrin! Website Twitter Connect with Yumlish! Website Instagram Twitter Facebook LinkedIn YouTube Key Points: 0:00-Intro with Shireen! 2:01-What drew you to medicine and how did you become involved in pediatric medicine? 2:31-Can you briefly describe the current state of childhood obesity in the United States? 3:49-How do clinicians generally approach childhood obesity prevention with parents and families? What improvements, if any, can be made with provider-patient interactions? 9:10- How can healthcare professionals better help parents and caregivers navigate these “toxic food environments”? 11:05-How has the COVID-19 pandemic affected stress, food insecurity, and obesity? 13:42-How can parents best support children's healthy lifestyles? 16:58-How can our listeners connect with you and learn more about your work? 18:31-Outro with Shireen! --- Send in a voice message: https://anchor.fm/yumlish/message

In this special “Meet the Expert” episode, two distinguished guests from Johns Hopkins University discuss their pioneering approach of applying methodologies, initially developed for astronomy, to the assessment of biomarkers of tumor microenvironment (TME). The guests are Dr. Janis Taube, director of Dermatopathology at Hopkins, and a co-Director of the TME Core at the Bloomberg-Kimmel Institute of Immunotherapy, and Dr. Alex Szalay, Bloomberg Distinguished Professor of Astronomy and Computer Science at Hopkins and the architect for the Science Archive of the Sloan Digital Sky Survey. The fascinating discussion focuses on an innovative multiplex imaging platform that they co-developed (AstroPath) for multidimensional assessment of spatially resolved interactions at the single-cell level of lung cancer and melanoma. See acast.com/privacy for privacy and opt-out information.

The COVID-19 pandemic has been already in our lives since late 2019 and the variants surge is rapidly increasing. Is there anything we can learn from the experience? Fast forward to the fall of 2021, what are the recommendations for Hospitals and Laboratories around the world for the current pandemic and future spread of diseases? In this podcast episode, we will have a conversation with Dr. Arturo Casadevall an infectious disease specialist and Bloomberg Distinguished Professor at Johns Hopkins University about learnings from this pandemic, vaccines, variants, and how antibody testing can play a key role. About our Speaker: Dr. Arturo Casadevall is a professor of medicine at the Johns Hopkins School of Medicine. He holds a joint appointment in molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. His research focuses on how microbes cause disease and how the immune system defends itself. Dr. Casadevall serves as chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He received his M.S., Ph.D., and M.D. from New York University. His team is currently engaged in understanding how hosts defend against the fungus Cryptococcus neoformans. Dr. Casadevall's work has been recognized with numerous awards, including the American Society for Microbiology Founders Distinguished Service Award, the National Institutes of Health Merit Award, and the Rhoda Benham Award from the Medical Mycology Society of America.  He was elected to the National Academy of Medicine and the American Academy of Arts and Sciences.

How can we help the planet by rethinking our diets? In a new book, Can Fixing Dinner Fix the Planet?, Dr. Jessica Fanzo, a Bloomberg Distinguished Professor of Global Food Policy and Ethics points out how our food options are often unhealthy for human bodies—and for the planet. Dr. Fanzo talks with Dr. Josh Sharfstein about making changes at both policy and individual levels, from the responsible use of genetically modified organisms to redesigning “choice architecture” in grocery stores and restaurants.

September is Prostate Cancer Awareness Month ***Ingrid J. Hall, PhD, MPH, is an epidemiologist in the Division of Cancer Prevention and Control's Epidemiology and Applied Research Branch. Dr. Hall's current research focus is in the area of minority health, particularly finding culturally relevant ways to publicize the need for participation in cancer screening and early detection by minority populations. Dr. Hall has a long history of published work in the area of prostate cancer decision making and spearheaded the organization and coordination of the State of the Science Conference on Active Surveillance in the Management of Localized Prostate Cancer convened in 2010. She currently oversees studies developing an interactive online educational tool for prostate cancer treatment choices as well as support materials for newly diagnosed men who choose active surveillance. ***Otis Brawley is professor of oncology at the Johns Hopkins University School of Medicine and 39th Bloomberg Distinguished Professor at Johns Hopkins. Dr. Brawley leads a broad interdisciplinary research effort of cancer health disparities at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, working to close racial, economic and social disparities in the prevention, detection and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland as the Kimmel Cancer Center's associate director for community outreach and engagement.  

In this two-part episode of Oncology, Etc., hosts Dr. Patrick Loehrer (Indiana University) and Dr. David Johnson (University of Texas) speak with Dr. Otis Brawley, a Bloomberg Distinguished Professor of Oncology at Johns Hopkins and former Executive Vice President of the American Cancer Society, about his incredible life and career. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air Date: 9/7/2021   TRANSCRIPT SPEAKER: The purpose of this podcast is to educate and inform. This is not a substitute for medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. No mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. PAT LOEHER: Hi. I'm Pat Loeher. I'm director of the Centers of Global Oncology and Health Equity at Indiana University Melbourne and Bren Simon Cancer Center. DAVID JOHNSON: And good morning. I'm Dave Johnson. I'm professor of Internal Medicine Oncology at the University of Texas Southwestern in Dallas. We're really excited to be back with the second episode of our ASCO Educational Podcast Oncology, et cetera. And I don't know about you, but my arm's really sore from entering all the fan mail we got from the first episode. Either that or maybe it was that shingles shot I got last week I don't know. PAT LOEHER: No, I agree. I really appreciate Bev. Your wife just kept texting me how wonderful I was, and it was-- I enjoyed it. DAVID JOHNSON: Well, I'm glad you mentioned that, because I wanted to read this one fan mail. It says, dear, Dave. Thanks for carrying Pat [INAUDIBLE]. I don't know who that is, but I appreciate it. PAT LOEHER: Yeah, it works both ways. Works both ways. So what have you been reading lately, Dave? DAVID JOHNSON: Well, as you know, I love to read. And actually what I'm reading right now is The Howe dynasty by Julie Flavell. It's about the brothers Howe that were involved in the Revolutionary War. But the book I finished just prior to the one I'm reading now is Adam Grant's Think Again, which I really enjoyed. It made me think again. What about you? PAT LOEHER: How many times have you read the book by the way? DAVID JOHNSON: Again. Twice. PAT LOEHER: Think again. Yeah. There was the book that's called The One Thing. I know if you saw that book which I read a while back. It took me, like, a year to do it, because I just kept doing other things while I was reading it. I felt so guilty about it. I did read the book Caste recently, and it was on Oprah Winfrey's list. Barack Obama picked it. And actually read that on my way to Kenya a couple of months ago and found it very fascinating actually. You know, the notion of the juxtaposing of Nazi Germany, of the caste system in India, and the racial struggles that was going on here in this country. And I thought it was a very well written book. DAVID JOHNSON: Yeah. You mentioned that book to me, and I finished reading it a couple of weeks ago. I agree with you. I enjoy it very much. I learned a lot. We want to introduce today's guest. We're really, really fortunate to have with us today Dr. Otis Brawley. Dr. Brawley Is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He's a graduate of the University of Chicago School of Medicine. He completed a residency in Internal Medicine at the University Hospitals in Cleveland Case Western Reserve and did a Fellowship in Medical Oncology at the National Cancer Institute, where he spent a good portion of his early career. In the 2000s, he relocated to Atlanta, where he became medical director of the Georgia Cancer Center for Excellence at Grady Memorial Hospital. One of the really most famous safety net hospitals in America. He was deputy director of Cancer Control at the Winship Cancer Institute of Emory University. And then he moved on to really a significant role. He became the chief medical and scientific officer and executive vise president of the American Cancer Society from 2007 to 2018, and we'll have a chance to perhaps query him about that. Currently, he leads a broad interdisciplinary research program on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center. Dr. Brawley has received innumerable awards. It would take the whole podcast to list them all. But among them are the American Medical Association Distinguished Service Award, University of Chicago Alumni of Professional Achievement Award, and-- one that I think is particularly poignant for ASCO members-- the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control. In 2015, Dr. Brawley was elected to the National Academy of Medicine and well deserved. So just welcome to oncology, et cetera. Thank you so much for taking the time to be with us today. OTIS BRAWLEY: Thank you for having me. It's a pleasure to be with you and Pat. DAVID JOHNSON: Well, it's great to have you. I can tell you that. So let's just start with just a little background. Why don't you tell us about yourself? Where are you from? Where did you grow up? OTIS BRAWLEY: I grew up in Detroit. I grew up in one of the automobile worker neighborhoods, a blue collar neighborhood, and went to the Catholic schools there. The nuns in grade school pushed me toward the Jesuit school for high school, and the Jesuits in high school taught me how to think and really propelled me. And indeed much of my career, much of my writings, my philosophy toward medicine was really influenced by early education with the Jesuits. DAVID JOHNSON: Wow. PAT LOEHER: Hey, Otis. I just want to throw in-- in terms of books that we've read, one of the other books that I want to give a shout out is the book you wrote called How We Do Harm, which was really a wonderful book. I think it was several years in the making. Would love to hear how you made that. But I do-- while you're talking about your background, speak a little bit about Edward McKnight Brawley and Benjamin. OTIS BRAWLEY: Oh, OK. Benjamin Brawley was my grandfather's brother, and Edward McKnight Brawley was my grandfather's father. They're both ministers in the Methodist Church, the AME Church. Benjamin Brawley was dean of Morehouse College back in the 1920s, and he was the first Brawley to graduate from the University of Chicago. He got a PhD from the University of Chicago back during the 19-teens. And those are just a couple of my relatives. If you go to Morehouse, you'll find that the English building is Benjamin Brawley Hall, and Edward McKnight Brawley was his father and was a free Black back before the Civil War, and a minister before, during, and after. PAT LOEHER: Incredible legacy. Incredible legacy. DAVID JOHNSON: Those were your relatives from the South from the Georgia area? OTIS BRAWLEY: Well, my father grew up in Northwestern Alabama. An area called Leighton, Alabama. It's near Muscle Shoals. So those of us who remember the Beverly Hillbillies. My mother is from the middle of Arkansas. She's from Pine Bluff, Arkansas. And they met in Detroit. They were part of that northern migration in the early 20th century, where a large number of Blacks left the rural South and went up North to get jobs primarily in the industrial North. My father arrived there right after World War II. He served in World War II, got discharged, and went to Detroit. My mother actually went to Detroit really early on during World War II and worked in an airplane factory during the war. Then the two of them met. My father was a janitor at the Veterans Hospital in Detroit, and my mother worked in the cafeteria there. And that's how they met. They had my older sister, who was 8 years older than me, who became an attorney. And my younger sister was a certified public accountant. PAT LOEHER: What a remarkable story for your parents. And tell us a little bit about your journey to become a physician. How did that happen? OTIS BRAWLEY: It was very interesting. In high school, I was very talkative. I was very interested in policy. I did debate. It was very not a sciencey kind of person. In college, I became very interested in Chemistry and for much of College. I was going to go to graduate school in Chemistry. And luckily, when I was in college, I came under the influence of an infectious disease doc named Elliot Kieff. And he and I became very good friends. He was chief of infectious disease at the University of Chicago at that time. And over about two years, Elliott convinced me to drop the Chemistry thing and go to Medical school. And I applied to Medical school late, because I was so late in making that decision. I got into the University of Chicago and stayed there because my support system was there. And then in Medical school came across another gentleman. I've been very fortunate to have good mentorship and good people. They influenced me over the years. John Altman, who was one of the original medical oncologists back in the 1950s when there was arguments about how we should be staging people. Should there be four stages or three stages, and that sort of thing is when John really cut his teeth in Oncology. He became a great lymphoma doc. John took me under his wing while I was in Medical school, and pretty much open the world up to me, and explained to me how the world rotates in Medicine. And that heavily influenced me. Told me to go into Oncology because I still had an interest in Policy. And he said there's going to be a lot of policy in oncology in the future, and the best way to get involved with it is to get your credentials as a medical oncologist. And in many respects, I think in the early 1980s, John was thinking I was going to be chief medical officer of the American Cancer Society, which I obtained in 2007. PAT LOEHER: Wow. Yeah. We want to hear more about that. I just have to throw this in parenthetically that one of the things I did here is that I applied late to Medical school and got into the University of Chicago. I just wanted to know that I applied early, and there was a lesser known school in Chicago that sent me a rejection letter. And not only did they reject me, the last line of it says, good luck in whatever career you decide to go into, meaning that, if you can't get into our school, there's no way you'll be a physician. So I really admire you. DAVID JOHNSON: Yeah. I applied late too and-- PAT LOEHER: Got into Vanderbilt. DAVID JOHNSON: No. No. No, no. I didn't go to Vanderbilt. I only got into accepted to one medical school, and it was late. I was just like my career as a chief. And I was, like, the last person admitted to my class in med school. That's unbelievably interesting. Tell us, was John your influence to go to the NCI? Or what prompted you to choose the NCI for your medical oncology training? OTIS BRAWLEY: Actually, John was very influential in that decision. I told him I wanted to go into medical oncology when I was a resident in Cleveland. And he said, Otis, in his Austrian accent, I have been expecting this phone call. And he then told me where I was going to apply and gave me a list of nine places to apply. He told me I would get an interview at every one of those places. And as I was going place to place, I should rank them one, two, three, four. And so I called them with his ranking. And my first choice was not the National Cancer Institute. At which point he told me, if you go to that place, I will never speak to you again. PAT LOEHER: Oh wow. OTIS BRAWLEY: And I said, but you told me to go there to interview. He said, I wanted you to interview there, but I don't want you to train there. And I said, well, my first choice is the National Cancer Institute. And he said, fine. And a couple of days later, I got a phone call from the National Cancer Institute, and I got hired. And I will also tell you I called John up. And he says, Otis, I have been expecting this phone call. And then he said, now I want you to realize something. There is an old boys network, and your job is to get more Blacks and women into it. That's how you will thank me. PAT LOEHER: Wow. Wow. DAVID JOHNSON: So you were at the NCI at a period of time where many people would say it was the heyday of the NCI. I think it's still the heyday now, but tell us about your experiences there. What was it like? OTIS BRAWLEY: It was fascinating. It was when Vince DeVita was still the director. I was there for the transition. Eli Glatstein was the chair of Radiation Oncology. It was an amazing group of people. Dan Longo was there doing lymphoma. Marc Lippman was still there doing breast. It was just an amazing group of people when I applied, and interviewed, and when I first got there. And there was still a lot of excitement. We were still heavily involved in chemotherapy. Of course, I was up on the 12th and 13th floor building 10. Down on the second and third floor was Dr. Rosenberg doing his immunotherapy work, which of course, has now paid off dramatically. Some of the old monoclonal antibody work that led to a number of wonderful drugs was being started at that time in the mid to late 1980s. And so it was still a very, very exciting time at the National Cancer Institute. And in many respects, we were still on that burst of optimism that started with Nixon's war on cancer in 1971. It was still felt almost 20 years later at the National Cancer Institute. DAVID JOHNSON: And you linked up with an old friend of mine from the old Southeast Cancer City, a gentleman by the name of Barry Kramer? OTIS BRAWLEY: Yes. DAVID JOHNSON: What a wonderful relationship. So how influential was Barry in your involvement? OTIS BRAWLEY: Barry was incredibly influential. As I said, I have been very fortunate that along the way I have come under the influence of some amazing physicians, and I've had amazing mentorship. And that's actually, I think, important for all of us in oncology. Barry and I got to work together for quite a long while. Barry influenced me and literally taught me epidemiology. Got me some major opportunities at the National Cancer Institute and really was influential in promoting me and boosting my career. PAT LOEHER: I want to move you a little bit longer in your career and talk about the ACS and a little bit your experience there, Otis. And then with that, actually, maybe the secondary question is, a commentary on the leaders over the years that you have had-- the aspects of good things about leadership and the poor things. And obviously, you have certainly much to share on that. OTIS BRAWLEY: Yeah. Well, as I devote my career at the National Cancer Institute, I went to the Division of Cancer Prevention and Control. Under Barry, learned a lot of epidemiology, and learned a lot about screening, learned a lot about treatment outcomes, got very involved with some of the disparities or minority health issues. And then I was very fortunate to be detailed to work in the surgeon general's office and work with David Satcher when he was surgeon general. He's the one who started using the words, health disparities. Prior to that, we called it minority health or special populations. He used health disparities. And I was able to use some of my epidemiologic talents to develop some of those arguments using science to show. And actually some of the things that we had to show, believe it or not, was we had to show that equal treatment yields equal outcome amongst equal patients, because a lot of people, especially the politicians we need to deal with, were really hung up. And we still see this to this day that people are hung up that Black biology is different from white biology. Even in breast cancer today I hear that even though I like to point out there are now six states where the Black death rate for breast cancer is the same as the white death rate for breast cancer. And there are 12 states in the United States where white women have a higher risk of death from breast cancer than Black women in Massachusetts. But anyway, we got into this biology thing. And so I was very fortunate again to work for David Satcher and had some exposure to Tuskegee syphilis trial and the president's apology for that. So I was really involved with a number of things. And then the Jesuits still back there-- always think, always be contemplative, always reflect on what you're doing, always question what you're doing. Father Pawlikowski's maxims, which Dick Cheney sort of preferred is a few years later. And that is there are things you know, things you don't know, things you believe. Question what you know more so than anything else. And so that's really how I develop my concerns about orthodox use of Medicine. And using the science and applying it in a very Orthodox way, I started realizing that a lot of the disparities were due to wasted resources with people being non-scientific especially in the era of the 1990s, where everybody was doing prostate cancer screening, and there was not a single trial to show that prostate cancer screening saved lives. Yet all the resources were going into that, and people were literally-- I was able to go to various safety net hospitals and see all the resources being diverted away. People would shut down cervical cancer screening programs to do prostate cancer, which just didn't make sense. So I got very interested in how you practice medicine. Went to the Emory in 2001, because I wanted some practical experience outside of government. And had a wonderful opportunity to go there. Work at Emory. Work at one of the largest safety net hospitals in the country. Learn a little bit about the practical application of Medicine and some of the problems that people at safety net hospitals encounter. Worked with the School of Public Health and folks who did health education to learn how to convey messages. And then I was very fortunate. You know, the American Cancer Society is right down the street from Emory University. And I had met the chief medical officer of the American Cancer Society, Harmon Eyre, back in the 1990s when I was at the National Cancer Institute. And again this sort of mentoring thing comes up again. Harmon called me up one morning and said, why don't we go to lunch? And so we went to one of the student cafeterias at Emory and had lunch. And he essentially said, you know, I'm 67 years old. I've had this job for 20 years. I'm tired of it. Why don't you take it? PAT LOEHER: Wow. OTIS BRAWLEY: And so I applied to be chief medical officer of the American Cancer Society and got to know John Safran, who, at that time, was the CEO, who was a wonderful man with incredible vision. Again, this mentorship thing comes up again. PAT LOEHER: Well, Dave we had a lot of information here. We're going to carry this over. This concludes the first part of our two-part interview with Dr. Brawley. And our next episode will air on October 5. We'll talk a little bit more about Dr. Brawley's life experiences and particularly his work with the American Cancer Society NCI. He's been an incredible individual, and we look forward to finishing up this conversation. Thank you to all our listeners for tuning in to Oncology Et Cetera an ASCO Education Podcast, where we'll talk about anything and everything. If you happen to have an idea for a topic or guest you'd like to see on the show, please email us at education@ASCO.org. Thanks again. And remember Dave has a face for podcast. SPEAKER: Thank you for listening to this week's episode of the ASCO eLearning weekly podcast. To make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit the comprehensive e-learning center at elearning.asco.org.

K-12 students and teachers across the country will be returning to in-person learning in the next couple of weeks. The CDC recently issued guidelines for making schools safe as the nation experiences a significant uptick in COVID-19 cases, particularly in the south. But mandates and requirements for masking and vaccination vary from jurisdiction to jurisdiction. To better understand the science behind school health policy options, we turn to Dr. Odis Johnson, the executive director of the Johns Hopkins Center for Safe and Healthy Schools and a Bloomberg Distinguished Professor of social policy and STEM equity. Dr. Odis Johnsonjoins us on Zoom. See omnystudio.com/listener for privacy information.

As a Bloomberg Distinguished Professor and Chair of the Department of Biochemistry and Molecular Biology, Dr. Ashani Weeraratna, Ph.D. has established an environment that challenges researchers and facilitates cancer research. She is an expert on melanoma metastasis, the Wnt signaling pathway, and the effects of aging on melanoma metastasis. Dr. Weeraratna also serves as president of The Society of Melanoma Research. Click on play to learn: What happens to healthy cells that are surrounded by cancer cells. How age-related changes at the molecular level may affect tumor cells. How cells are affected if they are a localized cancer versus a metastatic niche. The Weeraratna lab is known for cancer biology research and is currently studying the molecular mechanisms that lead to metastatic progression and therapy resistance. Dr. Weeraratna has conducted research on the molecular mechanisms and signal transduction pathways to determine what causes cells to become more aggressive and develop into melanoma tumors. The goal is to understand the age-related changes at a molecular level and identify how those changes affect tumor cells making them behave aggressively. Research continues on the effects of the tumor microenvironment on metastasis and therapy resistance. Researchers seek to understand how the aging microenvironment influences metastasis and therapy resistance, specifically in melanoma. In the short term, Dr. Weeraratna hopes to use an inhibitor to enhance the response to targeted therapies in older patients who are not eligible for immune therapy. In the long term, studies are focusing on age-related modifications such as life-style changes and/or medications to increase the chances of surviving cancer. The ultimate goal is to treat cancer as a chronic disease. In December 2021, Dr. Weeraratna's book, Is Cancer Inevitable? will be released. The book includes the personal story of her journey to become a respected cancer researcher. It also discusses the research she has been involved in such as the effects of aging on skin and corresponding changes in tumor growth as well as seeking ways to treat and prevent melanoma. To learn more visit: Website:          research.jhu.edu/members/ashani-weeraratna                            jhu.bmb.phd.org/ashani-weeraratna Twitter:           @AshaniTW Episode also available on Apple Podcasts: apple.co/30PvU9C

Tom's guest today is a MacArthur award-winning physician who is the founder and director of the Johns Hopkins Center for Health Equity.Dr. Lisa Cooper is a Bloomberg Distinguished Professor of Equity in Health and Healthcare, and Professor of Medicine at the Johns Hopkins School of Medicine. She is also the author of the new book, Why Are Health Disparities Everyone's Problem?, in which she makes a compelling argument for ending racial health inequities not just as a matter of moral imperative, but as a matter of political and social urgency as well. Dr. Cooper has done extensive research in a field that many in medicine ignore or marginalize. She has studied the dynamics between doctors and patients, and how those dynamics change when those interactions occur between people of different races. Why Black patients are less likely to trust their physicians, and what stigmas need to be overcome for healthcare to be allocated more effectively and fairly. A highly respected epidemiologist and public health expert, Dr. Cooper's perspective as a physician has been shaped by her childhood in Liberia, and her family's experience during that country's years of unrest and instability. Dr. Lisa Cooper joins us on our digital line… See omnystudio.com/listener for privacy information.

Presented in partnership with the Reginald F. Lewis Museum. Annette Gordon-Reed is in conversation with Lawrence Jackson about her new book, On Juneteenth. In ON JUNETEENTH, Gordon-Reed combines her own scholarship with a personal and intimate reflection of an overlooked holiday that has suddenly taken on new significance in a post-George Floyd world. As Gordon-Reed writes, “It is staggering that there is no date commemorating the end of slavery in the United States.” Yet, Texas—the last state to free its slaves—has long acknowledged the moment on June 19, 1865, when US Major General Gordon Granger proclaimed from his headquarters in Galveston that slavery was no longer the law of the land. ON JUNETEENTH takes us beyond the stories of Gordon-Reed's childhood, providing a Texan's view of the long, non-traditional road to a national recognition of the holiday. Gordon-Reed presents the saga of a frontier defined as much by the slave plantation owner as the mythic cowboy, rancher, or oilman. Reworking the “Alamo” narrative, she shows that enslaved Blacks—in addition to Native Americans, Anglos, and Tejanos—formed the state's makeup from the 1500s, well before Africans arrived in Jamestown. That slave-and race-based economy not only defined this fractious era of Texas independence, but precipitated the Mexican-American War and the resulting Civil War. A commemoration of Juneteenth and the fraught legacies of slavery that still persist, On Juneteenth is a stark reminder that the fight for equality is ongoing. Annette Gordon-Reed is the Carl M. Loeb University Professor at Harvard University. Author of the Pulitzer Prize–winning The Hemingses of Monticello: An American Family, she lives in New York and Cambridge, Massachusetts. Lawrence Jackson is the author of the award-winning books Chester B. Himes: A Biography and The Indignant Generation: A Narrative History of African American Writers and Critics. In 2002 he published Ralph Ellison: Emergence of Genius, 1913-1952 and he has written a memoir on race and family history called My Father's Name: A Black Virginia Family after the Civil War. Professor Jackson earned a PhD in English and American literature at Stanford University, and he is a 2019 Guggenheim fellowship awardee. A Bloomberg Distinguished Professor of English and History at Johns Hopkins University, he founded the Billie Holiday Project for Liberation Arts to create opportunities for enhanced intellectual and artistic relations between Hopkins and Baltimore City, his hometown. He is completing a book about his return called Job's Labyrinth, or, Shelter. The Brown Lecture Series is supported by the Eddie C. and C. Sylvia Brown Foundation. Recorded On: Wednesday, June 23, 2021

In this episode, we talked with Dr. Kathryn McDonald, a Bloomberg Distinguished Professor at Johns Hopkins University. We discuss the impact of visible factors, such as race, age, and sex, on medical diagnoses. We also explore the challenges of the patient-physician interaction and how we can advocate for ourselves in a healthcare setting.

Hanna Pickard is a Bloomberg Distinguished Professor of Philosophy and Bioethics at Johns Hopkins University. She is also appointed with the William H. Miller Department of Philosophy, the Berman Institute of Bioethics, and the Department of Psychological and Brain Sciences. Her expertise is deep and spread across a wide variety of disciplines. As an analytic philosopher, she specializes in philosophy of mind, philosophy of psychiatry, moral psychology, and clinical ethics. She also worked for a decade at The Oxfordshire Complex Needs Service, a specialist service in the NHS for people diagnosed with personality disorders and complex needs. Her work tends to address the sticky debates that arise in clinical practice. She has over 35 academic publications and has co-edited The Routledge Handbook of Philosophy and Science of Addiction. Pickard maintains an important thread between clinical work in the real world and her philosophical writings, attending to topics like the nature of mental disorders, delusions, agency, character, emotions, self-harm, violence, placebos, therapeutic relationships, decision-making capacity, the self and social identity, and attitudes towards mental disorder and crime. In this interview, she discusses her novel and possibly controversial model for understanding addiction, the numerous shortcomings of the neurobiological model, the importance of centering patient agency, and her work in therapeutic communities.

It's been just over a year since the first coronavirus case was reported in the United States, and the virus continues to spread rapidly through our communities. Last spring, we spoke with Dr. Arturo Casadevall – an infectious disease specialist and Bloomberg Distinguished Professor at Johns Hopkins University who was leading a team of experts to develop a convalescent blood plasma therapy for health care workers and for early treatment of COVID-19 patients. To help launch this research, Bloomberg Philanthropies, Maryland Governor Larry Hogan and Johns Hopkins worked together to provide early funding for the potential therapeutic uses of convalescent plasma. Fast forward to earlier this month, when the Mayo Clinic published a study showing antibodies in convalescent blood plasma therapy help lower mortality rates in over 3,000 coronavirus patients. While the COVID-19 vaccine continues to roll out, blood plasma therapy can help to save the lives of patients already infected with the coronavirus - and the Red Cross reports that hospital distributions of convalescent plasma for COVID-19 patents have increased by 250% since October. On this episode, Dr. Casadevall joins Dr. Jessica Leighton of the Bloomberg Philanthropies public health team to tell us more about how his research has progressed over the past few months, if convalescent blood plasma therapy and the vaccine are effective for new coronavirus strains, and how you could help save lives in your community. If you’ve recovered from COVID-19 and are interested in donating your blood plasma to others, please visit redcrossblood.org.

When the food industry promises to police itself and pledges to improve nutrition in public health, can it be trusted to make meaningful change or must government mandate those changes? Our two guests today have done groundbreaking work to help address this very question. Dr. Jessica Fanzo, Professor of Global Food and Agricultural Policy and Ethics at Johns Hopkins University, and Dr. Jennifer Harris is Senior Research Advisor for Marketing Initiatives at the Rudd Center for Food Policy and Obesity at the University of Connecticut. Interview Summary So Jess, let's begin with you. You coauthored what I thought was a very important and novel report released by the Global Alliance for Improved Nutrition on product reformulation by the food industry. Would you might explain what's meant by reformulation? When we think about reformulation, it's really defined as the process of all-terrain a food or a beverage product. You can alter that by improving the products' health profile or reducing the content of harmful nutrients or ingredients. So it's a process of either removing those negative ingredients or nutrients or adding back positive ones into foods. Why is that done? Because people consume a lot of processed foods. Almost every food that we consume has gone through some form of processing, but there's a whole range of that processing from very minimal to very highly processed, what's often called ultra-processed or junk food that doesn't have a lot of nutritional value. In the report, we were looking at what are the challenges with reformulating food? What are some of the opportunities to reformulate food? And in the realm of reformulation, has it had a positive impact on public health? So we were looking at those aspects of the reformulation of processed foods. So I'm assuming there could be enormous advances to public health if reformulation were done on a broad scale and or if it were done in a meaningful way. So what were your main findings then? Have there been examples of industry being successful with voluntary reformulation? Somewhat. And absolutely it could have potentially really important positive impacts for public health, but it's also not a panacea for improving diets and nutrition. And while there are some examples where voluntary reformulation has had some impact, the UK with salt and some other examples, overall we found that it's important for governments to mandate reformulation through different tools, whether it's labeling, taxes, et cetera. For foods that are not reformulated, we felt that it was really important for governments to mandate with clear, transparent and direct targets, particularly removing the unhealthy ingredients like added sugars, salts, unhealthy fats like trans fats. The food industry should be involved in implementing reformulation policies but not in their design. And governments need to really step in and step up. But that said, that doesn't mean that reformulation is going to solve all the problems. Governments also need to invest in many other tools to protect consumers and to invest in other ways to improve diets for nutrition. So reformulation shouldn't be the only answer. So I'm assuming the reason that food industry won't go far enough on their own is that these things that make the food less healthy also tend to make them pretty palatable, or give them long shelf life or properties that make people enjoy them a lot. And that why in the world would they do something that would make their products less desirable? Does that pretty much the case or do you see other reasons why? That's definitely true. I mean, these highly processed foods are cheap in their ingredients to make, they are very palatable, there's a high demand for them. We're seeing this shift now into low-income countries like with tobacco when consumers catch on that these foods are not so healthy, they go to populations where there's a bit of a lag in that knowledge. But also reformulating foods from the industry's perspective is not so easy. It's quite expensive to do it. It's difficult to reduce salt and sugar, which are vital not only for the taste of foods, but for their composition and shelf-life and texture. So it has a lot of ramifications to remove those ingredients. So meeting government mandates around reformulation can be really challenging and sometimes impossible for companies. So they often will deal with getting a warning label, for the example in Chile, they'll just take the warning label because they can't reformulate some foods. But there's a change in consumer demand and tastes. Consumers like their brands, but the more and more consumers are caring about clean labels, environmental sustainability, their health, people are concerned about the amount of sugar in foods so they're going to have to answer to that, that changing demand as consumers demand better foods whether it's from a health or sustainability or transparency perspective. Let me ask one more question related to this. Is it also the case that it's pretty difficult for some company to be the first out of the gate if they were inclined to do this voluntarily because then their products would become less desirable and their competitors would be kinda stuck in the old ways? So isn't that another argument for government intervening that everybody is on the same playing field? Absolutely, yes. I mean, why not hold every player accountable and to the same standards and mandates? It pushes them all to take action. So when we were interviewing some of the industry players, they really struggle because when they did try to reformulate some of the foods, consumers no longer bought them because they're very wedded to their brands, they're wedded to certain tastes, it's a real challenge for them to keep their consumer base. But at the same time, try to adhere to government mandate. And some companies care more about health and sustainability than others. We definitely learn that some companies have no interest in that, because they know they'll always be a big consumer base for these quote less healthy foods. So there's a real issue from company to company of who's willing to take more action to reformulate and who doesn't really care to reformulate at all and they're willing to live with warning stickers and taxes. So Jennifer, let's turn to you. So you've done really pioneering work on the impact of food marketing on children that began when we were colleagues together at the Rudd Center when it was at Yale University. And there I was witness to the fact that you created a very impressive methodology for studying what's a pretty complicated issue. And you paid a lot of attention to industry promises for self-policing of children's food marketing. Do you mind giving us a quick sense of what's being marketed to who and how, and how much marketing children are exposed to? Annually, companies spend over $13 billion in advertising food to all consumers. And just to put that number in perspective, the whole chronic disease prevention budget at the CDC is 1 billion. So the companies are really controlling the messages about what people should eat. And most of that money is spent to advertise very unhealthy products. The products that are contributing to poor diet and disease in this country. The biggest ones are fast food, sugary drinks, sweet and salty snacks and candy. Those categories represent about 80% of all foods that are advertised. Healthier categories of foods, if you look at all of juice, water, fruits, and vegetables and nuts combined, it's less than 3% of the total. So they're really pushing these very high fat, high sugar, high salt products extensively. Companies spend most of their advertising dollars on television ads. On an annual basis, kids see about 4,000 of those ads per year. So almost 4,000 ads, that's over 10 a day for unhealthy food. Kids of color, so black kids see twice as many of those ads. A lot of the worst products, their advertising is targeted to Black and Hispanic communities and especially adolescents. But TV isn't the only way companies advertise. And in the last few years, the ways that companies market just increased exponentially. Now with smartphones and tablets, they can reach kids any place and any time through things like ads on YouTube videos, social media, smartphone apps, with games and ordering programs, even educational websites teachers are using in grade school have ads on them. This kind of marketing is personalized. So what you see depends on what you do online. They know who you are and they can reach you. And unfortunately, this kind of marketing also is the kind of thing that parents can't monitor as easily as what your child is watching on TV. So the companies basically try to be wherever the consumer is to reach them with their advertising. Well those are really stunning numbers. I know one of the arguments the industry has made for years, and one of the things that you've addressed directly in your research is their claim that this food advertising doesn't really make kids or adults eat an unhealthy diet, it just shifts their preference from brand to brand. So if Coke is advertising a lot, they might say, "Well we just wanna take market share from Pepsi, "but we're not encouraging sugar beverage consumption." What would you say to that? That is something they've argued for a long time. And one thing that we showed is that just watching a television program with food advertising makes kids and adults eat a lot more both while they're watching and afterwards. And another of our colleagues, Ashley Gearhardt has done some really interesting research showing how the food advertising actually activates the reward regions of the brain and leads to increased consumption. So that's one way that food marketing affects more than brand preferences. There's also been a lot of research showing that if you advertise Coke, it increases consumption and purchases of all sugary drinks. They also affect sales of the categories, not just the specific brands. So with you and others doing so much work showing how much of the marketing there is and how disastrous the impact is, you can imagine the industry feels vulnerable to the possibility of outside regulation or perhaps even litigation. And so one of the things the industry has done and this links back to what Jessica was talking about in the context of reformulation, is to say that they can police themselves. So can you explain how they've gone about doing that? Well in the US there's a program called the Children's Food and Beverage Advertising Initiative, which is the food industry self-regulatory program to address food advertising to kids. And there are similar programs in countries around the world. But basically what the industry has promised is that they will only advertise products that meet nutrition standards in child directed media. That sounds really great. They implemented the program in 2007, but you said Kelly, we've done a lot of research showing how many limitations and loopholes there are in this program. One is that they only define children as 11 years and younger. So they only have promised to reduce unhealthy advertising to young children. And more and more of the research is showing that adolescents are just as affected and maybe even more effected by the advertising. Since their program was implemented, they've increased their advertising to the slightly older group that isn't covered by the CFBAI. Another limitation is their definition of what is child directed is advertising in media where children are the primary audience. So on television that would basically be children's TV. So Nickelodeon, Cartoon Network, those kinds of programs. But children watch a lot more television than just children's television. And so they can still advertise anything they want on programs that are also watched by adults and older children. And then the third major limitation is that they've set their own nutrition standards. So they have defined what is healthy. And maybe not surprisingly, a lot of the products that they say are healthier choices that can be advertised to kids are things like sugary cereals, fruit drinks that maybe have less sugar but they also have artificial sweeteners in them. Things like goldfish crackers, fast-food kids' meals, all of those can still be advertised to children under their nutrition standards. What we found is since the program was implemented in 2007, food advertising on children's television has gone down quite a bit, 45%. But at the same time, advertising on other types of television that children watch has gone up about 30%. So now kids see almost as much food advertising as they used to, but most of it is not on children's television, it's on the other kinds of television that they're watching. And a lot of the harder things to monitor, things like apps and social media and websites do not qualify as child directed media under this program. Now the reason I asked both of you to be on this podcast at the same time as I figured there would be interesting similarities, even though you're working on somewhat different topics, and boy does it turn out to be they're real themes weave through this. So let's talk next about what might be done then. So Jessica, with your work on industry reformulation, what have you concluded can be done voluntarily? Kelly, I think government needs to be much more involved than they are. The challenges that we see with voluntary regulation, whether it's in reformulation or marketing of unhealthy foods to children, we know that voluntary reformulation, industry sets its own agenda, they set their own targets, they have no accountability to meet those targets, they may pledge to reduce harmful ingredients but if the product has a very high level of these unhealthy ingredients, the reformulation may not make much of a difference from a public health point of view. So I think we need much more regulation. Governments need to hold industry accountable and ensure that they are meeting national standards for public health. I think government has been too laissez-faire about industry and the power that they hold. And I think now we're seeing the consequences of that not only in the United States, but everywhere in the world with rising levels of obesity and NCDs and unhealthy diets being a big risk factor with these processed foods playing a huge role in that. So we really need to see government step up in a much more profound way and hold industry having public health goals. It's a little bit of enough is enough. So Jess, just out of curiosity, let's say you were the government official in charge of taking such action and you have the authority to do it, where would you start? Would you start with particular nutrients across the food chain or would you start with certain categories of food and would you worry first about sugar, salt, fat? That's a good question. In the paper we outline four types of processed foods. To me I would probably look across the entire food supply chain at those highly, highly processed foods. And it would be good to start with at least the three categories of sugars, salt, and trans fats to even start with and setting key targets for those and marking those ultra-processed foods that go beyond that target. Chile had the great food law that's been enacted that's put warning labels on the front of packages and has regulated I think some of the advertising of those foods. Jennifer you probably know about this. And I think that's been an important case study for the rest of the world to look at of how Chile has done that because sales of those foods that have the warning label have gone down somewhere in the ballpark of I think between 23 and 28%, depending on the population. But I think there's lessons to be learned of how Chile has done that that other governments could learn from. Now I'm happy that you pointed out the advances in Chile because there have been some very impressive impacts reported from the studies that have been done so far. So I agree that that is really a model to look to. So Jennifer, let's just get your opinion on this. Where do you come down on this issue of voluntary versus mandated? So we've given the industry 12 years now to show that they can market healthier products to kids. And basically what they've done is they're marketing slightly healthier products to kids but the products they're marketing are not nutritious products that children should be consuming a lot of like sugared cereals. So it's pretty clear that they can't do it on their own and that regulation is required. In the US, we have a little bit of an issue that not all countries have because of the First Amendment. And advertising is protected speech according to the Supreme Court. So we can't just say companies cannot advertise anything. So we have to be more strategic about the kinds of regulations that we can implement here. If we could do anything we wanted, Chile is a great example. In the next year, they won't be able to advertise any products that are high in fat, sugar and salt before 9:00 p.m. So it's not just children's programming, they won't be able to advertise it. They had to take all their characters off their packages. And so Tony the Tiger can't be on the package of frosted flakes anymore because it's high in sugar. They've done a lot of great things in Chile and sure we can adapt some of what they've done. In other countries also, for example the UK has very strong laws about marketing foods in digital media. So that would be another thing that we could import from other countries.   Bios   Jessica Fanzo, Ph.D., is the Bloomberg Distinguished Professor of Global Food Policy and Ethics at the Berman Institute of Bioethics, the Bloomberg School of Public Health, and the Nitze School of Advanced International Studies (SAIS) at the Johns Hopkins University in the USA. She also serves as the Director of Hopkins' Global Food Policy and Ethics Program, and as Director of Food & Nutrition Security at the JHU Alliance for a Healthier World.  From 2017 to 2019, Jessica served as the Co-Chair of the Global Nutrition Report and the UN High Level Panel of Experts on Food Systems and Nutrition. Before coming to Hopkins, she has also held positions at Columbia University, the Earth Institute, Food and Agriculture Organization of the United Nations, the World Food Programme, Bioversity International, and the Millennium Development Goal Centre at the World Agroforestry Center in Kenya. She was the first laureate of the Carasso Foundation's Sustainable Diets Prize in 2012 for her research on sustainable food and diets for long-term human health. Jennifer Harris, Ph.D., is a Senior Research Advisor, Marketing Initiatives at the Rudd Center. Previously, Dr. Harris worked as Director of Marketing Initiatives and was an Associate Professor in Allied Health Sciences at the University of Connecticut. Harris received her B.A. from Northwestern University and M.B.A. in Marketing from The Wharton School. Before returning to graduate school, she was a marketing executive for eighteen years, including at American Express as a Vice President in consumer marketing and as principal in a marketing strategy consulting firm. Harris completed her PhD in Social Psychology at Yale University with John Bargh and Kelly Brownell.

Virtual Event - Information Needs for Food Crisis Risk Early Warning: The Role of the Food Security Portal Co-Organized by IFPRI and the Food Security Portal (FSP) NOV 24, 2020 - 09:30 AM TO 11:00 AM EST Persistent drivers of food insecurity and acute hunger—conflict, climate shocks, and environmental shocks—have been compounded in 2020 by the COVID-19-related health and socioeconomic upheaval and by the severe desert locust outbreaks in East Africa. The pandemic is expected to push as many as 132 million more people into chronic hunger in 2020, in addition to the 690 million who went hungry in 2019. To navigate the increasingly complex, interlinked causes of food crises, governments and other stakeholders require timely, high-quality information to increase the resilience of food systems and cope with future crises. The EC-funded Food Security Portal (FSP)( http://www.foodsecurityportal.org/), initiated in 2010 in response to lessons learned from the 2007–2008 world food crisis, seeks to improve governments’ ability to respond to and prevent food crises by bringing together policy-relevant tools and information in one place. The FSP is designed to pool timely, relevant, detailed and high-quality country-level information in a systematic way. This policy dialogue focused on data and information sharing and coordination for improving food security, with a focus on the role of the FSP in monitoring the drivers of food insecurity and food crises to inform policies. New tools and features of the FSP and the Africa South of the Sahara sub-portal have recently been added to the upgraded website. Opening remarks: Conrad Rein, Policy Officer, European Commission, and Co-Chair, Global Donor Platform for Rural Development Introduction to the Upgraded Food Security Portal: Rob Vos, Division Director, Markets, Trade and Institutions, IFPRI Panelists: Ousmane Badiane, Executive Chairperson, Akademiya2063 Arif Husain, Chief Economist, World Food Programme (WFP) Jessica Fanzo, Bloomberg Distinguished Professor of Global Food & Agricultural Policy and Ethics, Johns Hopkins University Máximo Torero, Chief Economist, Food and Agriculture Organization of the United Nations (FAO) Closing remarks: Philippe Thomas, Head of Sector, Food and Agricultural Systems, Crisis and Resilience, European Commission Moderator Teunis van Rheenen, Director of Business Development and External Relations & Acting Chief of Staff, IFPRI LINKS: Book: COVID-19 And Global Food Security: http://bit.ly/IFPRICovidBook Food Security Portal: https://www.foodsecurityportal.org/ IFPRI Resources And Analyses Of COVID-19 Impact: https://www.ifpri.org/covid-19 More on the seminar: https://www.ifpri.org/event/virtual-event-information-needs-food-crisis-risk-early-warning-role-food-security-portal Subscribe IFPRI Insights newsletter and event announcements at www.ifpri.org/content/newsletter-subscription

Astronomers rocked the cosmological world with the 1998 discovery that the universe is accelerating. Well-deserved Nobel Prizes were awarded to Saul Perlmutter, Brian Schmidt, and today’s guest Adam Riess. Adam has continued to push forward on investigating the structure and evolution of the universe. He’s been a leader in emphasizing a curious disagreement that threatens to grow into a crisis: incompatible values of the Hubble constant (expansion rate of the universe) obtained from the cosmic microwave background vs. direct measurements. We talk about where this “Hubble tension” comes from, and what it might mean for the universe.Support Mindscape on Patreon.Adam Riess received his Ph.D. in astronomy from Harvard University. He is currently Bloomberg Distinguished Professor and Thomas J. Barber Professor of Physics and Astronomy at Johns Hopkins University and a Senior member of the Science Staff at the Space Telescope Science Institute. Among his many awards are the Helen B. Warner Prize of the American Astronomical Society, the Sackler Prize, the Shaw Prize, the Gruber Cosmology Prize, the MacArthur Fellowship, the Breakthrough Prize in Fundamental Physics, and the Nobel Prize.Johns Hopkins web pageSpace Telescope Science Institute web pageNobel LectureGoogle Scholar publicationsTalk on the expansion rate of the universeWikipedia

This episode of Tuning Into The C-Suite welcomes our first of many episodes part of the new “Meet the Board” podcast series. Listeners will not only hear from C-Suite executives each week, but will hear from a member of Managed Healthcare Executive's Editorial Advisory Board. A new episode featuring our board members will be aired once a month at the end of each month. The first guest featured in the series is Otis Brawley, a physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. Brawley is also most known as the former chief medical and scientific officer and executive vice president of the American Cancer Society.

Tune in to The College Neuro Network's ninth episode where we chat with Dr. Daeyeol Lee, a Bloomberg Distinguished Professor of Neuroscience and Psychological and Brain Sciences at Johns Hopkins University and Professor Adjunct of Neuroscience at Yale University. Because of Dr. Daeyeol Lee's impressive position as a Bloomberg Distinguished Professor, today, we'll be discussing 2 rather than 1 university! The College Neuro Network seeks to gain insight into the neuroscience department and opportunities at the most prestigious universities in the nation by talking with both undergraduate students as well as professors of neuroscience. In today's episode, learn about neuroscience at both Johns Hopkins and Yale directly from a professor who holds positions at both! Episode Hosts and Editors: Sarah Mirsaidi and Sasha Tunsiricharoengul

  Nobel Prize-winning astronomer Adam Riess is my guest on this episode of INTO THE IMPOSSIBLE. Adam was an essential character in my book, Losing the Nobel Prize. Though at the top of his field, Riess is relentlessly passionate about perfecting his craft and he credits curiosity as the force that sustains his career. Riess and I discussed cosmological controversies including inflation, the Hubble tension, and primordial magnetic fields. We also discuss legacies, prize money, Albert Einstein’s ability to transfix physicists and laypeople.  07:02 Curiosity is the key to a fulfilling career in science. 18:22 9% and why it matters. 26:00 Einstein was a victim of bad data. 33:02 Resolving Hubble tension. 40:56 The pursuit of extraordinary evidence. 52:03 What ethical will does Adam plan to leave behind? 53:28 What would Adam put on a billion year old time capsule? 55:44 What wisdom would Adam share with his younger self? 57:53 How did Adam spend his Nobel Prize winnings? Adam Riess was a recipient of the 2011 Nobel Prize in Physics. He is a Bloomberg Distinguished Professor, and the Thomas J. Barber Professor in Space Studies at the Krieger School of Arts and Sciences at Johns Hopkins University. He is also an Astronomer at the Space Telescope Science Institute. He received his PhD in Astrophysics from Harvard University with Bob Kirshner. Adam Riess talks about his latest paper on the podcast “Cosmology Talks” here: https://youtu.be/2LN6dJi0og Find Adam Riess on the web: https://www.stsci.edu/~ariess/ Into The Impossible is a Production of the Arthur C. Clarke Center For Human Imagination. http://imagination.ucsd.edu @imagineUCSD Our four areas of exploration are: The neuroscience of imagination Science fiction and speculative culture Space and the cosmos Art and science as tools of the imagination ️Please subscribe, rate, and review the INTO THE IMPOSSIBLE Podcast on iTunes Learn more about your ad choices. Visit megaphone.fm/adchoices

Economist Matthew E. Kahn, the Bloomberg Distinguished Professor of Economics and Business at Johns Hopkins University and the director of the university’s 21st Century Cities Initiative, discusses the idea of the American Dream, his support for a per-ton carbon tax, and why, because of the climate crisis, he doesn’t believe in homeownership.

Otis Brawley, MD, a globally recognized expert in cancer control, joins National Coalition for Cancer Survivorship (NCCS) CEO Shelley Fuld Nasso for a conversation about the COVID-19 coronavirus pandemic and how it is affecting cancer survivors, care delivery, and cancer research. Dr. Brawley is a Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University in Baltimore, MD.

This podcast discusses the results and implications of a recent study on gender bias in speaker introductions at an international oncology conference. This JCO Podcast provides observations and commentary on the JCO article "Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference" by Duma et al. My name is Dr. Tatiana Prowell. I am an Associate Professor of Oncology at Johns Hopkins Kimmel Cancer Center and Breast Cancer Scientific Liaison at the U.S. Food and Drug Administration in Silver Spring, Maryland. My oncologic specialty is breast cancer. In the article that accompanies this podcast, Duma and colleagues report the results of a retrospective observational study of speaker introductions at two consecutive years of ASCO Annual Meetings. The investigators hypothesized that female speakers in oral sessions would be introduced with a professional form of address less frequently than male speakers. For the purposes of the study, they defined a professional address as use of a title such as Professor or Doctor, followed by the speaker’s full name or last name, or the speaker’s full name followed by doctoral degree. A team of four male and four female reviewers analyzed 781 video recordings of oral sessions from the 2017 and 2018 ASCO Annual Meetings and recorded the gender of the introducer and speaker and how the speaker was introduced. They found that female speakers received a professional form of address 62% of the time whereas male speakers were introduced professionally 81% of the time, a difference that was statistically significant. Duma and her colleagues also assessed whether the gender of the introducer was associated with a difference in the likelihood of receiving a professional introduction. They found that male moderators introduced female speakers professionally a little more than half the time, whereas they introduced men professionally in 80% of cases.  Interestingly, when serving as introducers, women were more likely than men to include a professional form of address, which they did about three-quarters of the time, regardless of whether they were introducing men or women.  Perhaps the most striking result of the study was that one in six female speakers was introduced by her first name only, a surprising degree of informality for a high-profile conference like the ASCO Annual Meeting, which draws more than 40,000 attendees per year. By comparison, male speakers were introduced by first name alone in just 3% of presentations. In a multivariate analysis that included gender, degree, academic rank and geographic location of the speaker’s institution, male speakers were 2.5 times more likely to receive a professional introduction compared to female speakers.    This study adds to a growing body of literature in medicine investigating the prevalence of gender bias in speaker introductions. For example, previous studies of speaker introductions over a 3 year period of Mayo Clinic Internal Medicine Grand Rounds and at an American Society of Colon and Rectal Surgeons Annual Meeting reported similar findings. In both cases, female speakers were less likely than men to be introduced using a professional form of address, and women introducers more consistently referred to speakers by a professional title, regardless of whether the speaker they were introducing happened to be a man or a woman.   This study raises two key questions: why do we see this, and how can we fix it? A speaker introduction, especially at an international conference, is by definition a formal ritual, and yet one so familiar to us that we may have lost sight of its purpose. It would be easy enough for speakers to introduce themselves. Every speaker has an opening slide that shows his or her name and institutional affiliation. So why choose someone, and often someone well-known within the field, whose role is to introduce the speakers at all?  What leads us to say, “Dr. Carol Greider is Bloomberg Distinguished Professor, Director of Molecular Biology and Genetics at Johns Hopkins University, and a recipient of the 2009 Nobel Prize in Medicine”? I believe we do this for two reasons. First, formal introductions provide a moment, however brief, to demonstrate our collective respect for the speaker and his or her scientific contributions. Second, the information in the introduction signals to any who are not familiar with the speaker that the person is credible, knowledgeable, and worthy of our attention. Although more than 50% of medical school matriculants and about 40% of medical school faculty are women, they remain underrepresented at higher academic ranks and in leadership roles. Only about one-quarter of full professors are women, and fewer than 1 in 5 department chairs are women. Women are also less likely than men to be the first or senior author of manuscripts and thus less likely to be standing at the podium. As a result, the names and work of women in medicine may well be less familiar to the audience. Female introducers may therefore be more likely to assign value to use of a professional form of address. If this were true, one might expect to see women more consistently use a professional form of address when introducing speakers, and this is in fact what Duma and her colleagues observed.    The more troubling question is why men approached the introduction of male and female speakers so differently and why male speakers were 2.5 times more likely to be introduced with a professional title than women. I believe that most moderators, if presented with data from their own sessions, would be surprised to learn that they introduce men and women differently. This is called unconscious bias, and we are all susceptible to it. While the root causes of unconscious gender bias are numerous, one of these is surely the dearth of women occupying senior positions in medicine. As a community, we have tremendous power to remedy this source of unconscious bias. But while we can all re-commit ourselves to mentoring and sponsoring women in order to create more visible examples of female leaders in medicine, these efforts will not change the face of medicine, nor eliminate our unconscious gender bias, overnight. And yet, this is a change that needs to be made now. A male colleague of mine described introducing a woman at the podium by her first name as the verbal equivalent of rubbing the shoulder of a female professional acquaintance, then extending a handshake to a male professional acquaintance, that is to say, an inappropriate degree of familiarity with the woman. However, even in circumstances where the introducer and speaker are well-known to one another, formal settings call for formality. I call my physician husband “honey” at home, but if I were moderating an ASCO Annual Meeting session in which he was a panelist and said “Honey, why don’t you take that question?” it would of course be ridiculous.  Using respectful forms of address in formal settings like conference sessions is ultimately a mark of professionalism and, in 2019, non-negotiable.    The good news is that, unlike many problems in medicine, this one has a couple of solutions that we can implement immediately. We can provide a simple standardized script at the podium that ensures all speakers receive an equitable introduction. All conferences should implement this now, and in fact, motivated by Duma and her colleagues’ work, session chairs will receive such a script for introductions at the 2020 ASCO Annual Meeting. Perhaps more importantly, though, we can appreciate the formal introduction as a ritual that has been conserved through generations of scientists for a reason. Regardless of our gender, all of us as physicians remember that feeling when were July interns and the attending said of us on rounds something like, “Dr. Smith will be back to explain the plan to you in more detail.” In that moment, when we were called Doctor before an audience of our patients and our peers, we felt respected, capable, confident, and proud. Let’s commit to ensuring that all of our colleagues have that feeling every time they take the podium.    This concludes this JCO Podcast. Thank you for  

Plugged In with Greta Van Susteren examines the global cancer crisis and the search for a cure. Insights from Dr. J. Leonard Lichtenfeld, Chief Medical and Scientific Officer for the American Cancer Society; Cary Adams, CEO of the Union for International Cancer Control; and Dr. Otis Brawley, Bloomberg Distinguished Professor of Oncology & Epidemiology at Johns Hopkins University. VOA's Mil Arcega anchors the show for Greta.

One of the greatest mysteries in biology, until 1991, was how water moves across cell membranes. Today’s episode focuses on the history of the discovery of aquaporins, or proteins that act as water channels in cell membranes. My guest is Peter Agre, recipient of the 2003 Nobel Prize in Chemistry for his discovery of aquaporins. Among many other honors and leadership roles across his career, Peter became a member of the U.S. National Academy of Sciences in 2000 and served as President of the American Association for the Advancement of Science from 2009-2010. He is the Bloomberg Distinguished Professor in Molecular Microbiology and Immunology and in the School of Medicine at Johns Hopkins Bloomberg School of Public Health. Peter is also the Director of the Johns Hopkins Malaria Research Institute.

Steven Salzberg is the Bloomberg Distinguished Professor of Biomedical Engineering, Computer Science, and Biostatistics at Johns Hopkins University. He also worked on the Human Genome Project, sequenced the genomes of many bacteria, and his research group develops software for DNA sequence analysis.   Links & Sponsors: breakitdownpod.com Facebook Rockabilia: rockabilia.com code PCBREAKITDOWN Learn more about your ad choices. Visit megaphone.fm/adchoices

In this definitive biography of Chester B. Himes, the African American author who had an extraordinary influence on black writers globally, Lawrence P. Jackson explores Himes' middle-class origins and his eight years in prison. He also recounts Himes' painful odyssey as a black World War II-era artist and his escape to Europe, where he became internationally famous for his Harlem detective series. Enhanced by friendships with Ralph Ellison, Richard Wright, and Carl Van Vechten, Himes published twenty literary works over a long career, including the bestsellers If He Hollers, Let Him Go and Cotton Comes to Harlem.Lawrence P. Jackson is Bloomberg Distinguished Professor of English and History at Johns Hopkins University. He is the author of The Indignant Generation and other works.Writers LIVE programs are supported in part by The Miss Howard Hubbard Adult Programming Fund.Recorded On: Wednesday, September 20, 2017

In this definitive biography of Chester B. Himes, the African American author who had an extraordinary influence on black writers globally, Lawrence P. Jackson explores Himes' middle-class origins and his eight years in prison. He also recounts Himes' painful odyssey as a black World War II-era artist and his escape to Europe, where he became internationally famous for his Harlem detective series. Enhanced by friendships with Ralph Ellison, Richard Wright, and Carl Van Vechten, Himes published twenty literary works over a long career, including the bestsellers If He Hollers, Let Him Go and Cotton Comes to Harlem.Lawrence P. Jackson is Bloomberg Distinguished Professor of English and History at Johns Hopkins University. He is the author of The Indignant Generation and other works.Writers LIVE programs are supported in part by The Miss Howard Hubbard Adult Programming Fund.

How can the humanities help to recover and celebrate the literature, history, and arts of African-American communities in West Baltimore? Lawrence Jackson, Bloomberg Distinguished Professor in the Departments of English and History at Johns Hopkins University, tells us about his new initiative, set to operate through JHU?s Center for Africana Studies beginning this summer.

Renee's guest is Kathryn Edin, a sociologist and a Bloomberg Distinguished Professor at Johns Hopkins University. She specializes in study of people living on welfare. Edin is author of $2.00 a Day: Living on Almost Nothing in America

Renee's guest is Kathryn Edin, a sociologist and a Bloomberg Distinguished Professor at Johns Hopkins University. She specializes in study of people living on welfare. Edin is author of $2.00 a Day: Living on Almost Nothing in America